Bone-growth regulatory factors that are members of the transforming growth factor-beta superfamily of proteins. They are synthesized as large precursor molecules which are cleaved by proteolytic enzymes. The active form can consist of a dimer of two identical proteins or a heterodimer of two related bone morphogenetic proteins.
A potent osteoinductive protein that plays a critical role in the differentiation of osteoprogenitor cells into OSTEOBLASTS.
A bone morphogenetic protein that is a potent inducer of bone formation. It also functions as a regulator of MESODERM formation during EMBRYONIC DEVELOPMENT.
A bone morphogenetic protein that is widely expressed during EMBRYONIC DEVELOPMENT. It is both a potent osteogenic factor and a specific regulator of nephrogenesis.
A subtype of bone morphogenetic protein receptors with high affinity for BONE MORPHOGENETIC PROTEINS. They can interact with and undergo PHOSPHORYLATION by BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE II. They signal primarily through RECEPTOR-REGULATED SMAD PROTEINS.
A family of CELL SURFACE RECEPTORS that bind BONE MORPHOGENETIC PROTEINS. They are PROTEIN-SERINE-THREONINE KINASES that mediate SIGNAL TRANSDUCTION PATHWAYS through SMAD PROTEINS.
A bone morphogenetic protein that is a potent inducer of BONE formation. It plays additional roles in regulating CELL DIFFERENTIATION of non-osteoblastic cell types and epithelial-mesenchymal interactions.
A subtype of bone morphogenetic protein receptors with low affinity for BONE MORPHOGENETIC PROTEINS. They are constitutively active PROTEIN-SERINE-THREONINE KINASES that can interact with and phosphorylate TYPE I BONE MORPHOGENETIC PROTEIN RECEPTORS.
A specialized CONNECTIVE TISSUE that is the main constituent of the SKELETON. The principle cellular component of bone is comprised of OSTEOBLASTS; OSTEOCYTES; and OSTEOCLASTS, while FIBRILLAR COLLAGENS and hydroxyapatite crystals form the BONE MATRIX.
A bone morphogenetic protein that may play a role in CARTILAGE formation. It is a potent regulator of the growth of CHONDROCYTES and the synthesis of cartilage matrix proteins. Evidence for its role in cartilage formation can be seen in MICE, where genetic mutations that cause loss of bone morphogenetic protein 5 function result in the formation of small malformed ears.
A receptor-regulated smad protein that undergoes PHOSPHORYLATION by BONE MORPHOGENETIC PROTEIN RECEPTORS. It regulates BONE MORPHOGENETIC PROTEIN signaling and plays an essential role in EMBRYONIC DEVELOPMENT.
A family of proteins that are involved in the translocation of signals from TGF-BETA RECEPTORS; BONE MORPHOGENETIC PROTEIN RECEPTORS; and other surface receptors to the CELL NUCLEUS. They were originally identified as a class of proteins that are related to the mothers against decapentaplegic protein, Drosophila and sma proteins from CAENORHABDITIS ELEGANS.
A bone morphogenetic protein that is found at high concentrations in a purified osteoinductive protein fraction from BONE. Bone morphogenetic protein 3 is referred to as osteogenin, however it may play a role in variety of developmental processes.
A receptor-regulated smad protein that undergoes PHOSPHORYLATION by BONE MORPHOGENETIC PROTEIN RECEPTORS. It regulates BONE MORPHOGENETIC PROTEIN signaling and is essential for PHYSIOLOGICAL ANGIOGENESIS.
A protein that plays a role in GRANULOSA CELLS where it regulates folliculogenesis. Mutations in the gene for bone morphogenetic protein 15 are linked to reproductive abnormalities such as PREMATURE OVARIAN FAILURE.
A bone morphogenetic protein family member that includes an active tolloid-like metalloproteinase domain. The metalloproteinase activity of bone morphogenetic protein 1 is specific for the removal of the C-propeptide of PROCOLLAGEN and may act as a regulator of EXTRACELLULAR MATRIX deposition. Alternative splicing of MRNA for bone morphogenetic protein 1 results in the production of several PROTEIN ISOFORMS.
A factor synthesized in a wide variety of tissues. It acts synergistically with TGF-alpha in inducing phenotypic transformation and can also act as a negative autocrine growth factor. TGF-beta has a potential role in embryonal development, cellular differentiation, hormone secretion, and immune function. TGF-beta is found mostly as homodimer forms of separate gene products TGF-beta1, TGF-beta2 or TGF-beta3. Heterodimers composed of TGF-beta1 and 2 (TGF-beta1.2) or of TGF-beta2 and 3 (TGF-beta2.3) have been isolated. The TGF-beta proteins are synthesized as precursor proteins.
The continuous turnover of BONE MATRIX and mineral that involves first an increase in BONE RESORPTION (osteoclastic activity) and later, reactive BONE FORMATION (osteoblastic activity). The process of bone remodeling takes place in the adult skeleton at discrete foci. The process ensures the mechanical integrity of the skeleton throughout life and plays an important role in calcium HOMEOSTASIS. An imbalance in the regulation of bone remodeling's two contrasting events, bone resorption and bone formation, results in many of the metabolic bone diseases, such as OSTEOPOROSIS.
An inhibitory Smad protein that negatively regulates the SIGNAL TRANSDUCTION PATHWAYS from BONE MORPHOGENETIC PROTEIN RECEPTORS. Smad6 inhibits PHOSPHORYLATION of SMAD2 PROTEIN and SMAD3 PROTEIN.
A receptor-regulated smad protein that undergoes PHOSPHORYLATION by BONE MORPHOGENETIC PROTEIN RECEPTORS and regulates BONE MORPHOGENETIC PROTEIN signaling.
The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway.
The process of bone formation. Histogenesis of bone including ossification.
A growth differentiation factor that plays a regulatory role as a paracrine factor for a diverse array of cell types during EMBRYONIC DEVELOPMENT and in the adult tissues. Growth differentiation factor 2 is also a potent regulator of CHONDROGENESIS and was previously referred to as bone morphogenetic protein 9.
Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs.
Bone-forming cells which secrete an EXTRACELLULAR MATRIX. HYDROXYAPATITE crystals are then deposited into the matrix to form bone.
Renewal or repair of lost bone tissue. It excludes BONY CALLUS formed after BONE FRACTURES but not yet replaced by hard bone.
The amount of mineral per square centimeter of BONE. This is the definition used in clinical practice. Actual bone density would be expressed in grams per milliliter. It is most frequently measured by X-RAY ABSORPTIOMETRY or TOMOGRAPHY, X RAY COMPUTED. Bone density is an important predictor for OSTEOPOROSIS.
Cell surface receptors that bind growth or trophic factors with high affinity, triggering intracellular responses which influence the growth, differentiation, or survival of cells.
A family of BONE MORPHOGENETIC PROTEIN-related proteins that are primarily involved in regulation of CELL DIFFERENTIATION.
A growth differentiation factor that plays a role in early CHONDROGENESIS and joint formation.
The growth and development of bones from fetus to adult. It includes two principal mechanisms of bone growth: growth in length of long bones at the epiphyseal cartilages and growth in thickness by depositing new bone (OSTEOGENESIS) with the actions of OSTEOBLASTS and OSTEOCLASTS.
Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action during the developmental stages of an organism.
A bone morphogenetic protein that plays an essential role in the regulation of ovarian folliculogenesis.
Extracellular substance of bone tissue consisting of COLLAGEN fibers, ground substance, and inorganic crystalline minerals and salts.
Bone loss due to osteoclastic activity.
One of the two types of ACTIVIN RECEPTORS or activin receptor-like kinases (ALK'S). There are several type I activin receptors. The major active ones are ALK-2 (ActR-IA) and ALK-4 (ActR-IB).
A growth differentiation factor that plays a role in the neural differentiation, specifically in the retinal development of the EYE.
Activins are produced in the pituitary, gonads, and other tissues. By acting locally, they stimulate pituitary FSH secretion and have diverse effects on cell differentiation and embryonic development. Activins are glycoproteins that are hetero- or homodimers of INHIBIN-BETA SUBUNITS.
Regulatory proteins and peptides that are signaling molecules involved in the process of PARACRINE COMMUNICATION. They are generally considered factors that are expressed by one cell and are responded to by receptors on another nearby cell. They are distinguished from HORMONES in that their actions are local rather than distal.
A signal transducing adaptor protein and tumor suppressor protein. It forms a complex with activated RECEPTOR-REGULATED SMAD PROTEINS. The complex then translocates to the CELL NUCLEUS and regulates GENETIC TRANSCRIPTION of target GENES.
Tumors or cancer located in bone tissue or specific BONES.
One of the two types of ACTIVIN RECEPTORS. They are membrane protein kinases belonging to the family of PROTEIN-SERINE-THREONINE KINASES. The major type II activin receptors are ActR-IIA and ActR-IIB.
Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others.
The soft tissue filling the cavities of bones. Bone marrow exists in two types, yellow and red. Yellow marrow is found in the large cavities of large bones and consists mostly of fat cells and a few primitive blood cells. Red marrow is a hematopoietic tissue and is the site of production of erythrocytes and granular leukocytes. Bone marrow is made up of a framework of connective tissue containing branching fibers with the frame being filled with marrow cells.
Diseases of BONES.
Cells contained in the bone marrow including fat cells (see ADIPOCYTES); STROMAL CELLS; MEGAKARYOCYTES; and the immediate precursors of most blood cells.
A broadly distributed protein that binds directly to ACTIVINS. It functions as an activin antagonist, inhibits FOLLICLE STIMULATING HORMONE secretion, regulates CELL DIFFERENTIATION, and plays an important role in embryogenesis. Follistatin is a single glycosylated polypeptide chain of approximately 37-kDa and is not a member of the inhibin family (INHIBINS). Follistatin also binds and neutralizes many members of the TRANSFORMING GROWTH FACTOR BETA family.
The processes occurring in early development that direct morphogenesis. They specify the body plan ensuring that cells will proceed to differentiate, grow, and diversify in size and shape at the correct relative positions. Included are axial patterning, segmentation, compartment specification, limb position, organ boundary patterning, blood vessel patterning, etc.
The middle germ layer of an embryo derived from three paired mesenchymal aggregates along the neural tube.
Receptors for ACTIVINS are membrane protein kinases belonging to the family of PROTEIN-SERINE-THREONINE KINASES, thus also named activin receptor-like kinases (ALK's). Activin receptors also bind TRANSFORMING GROWTH FACTOR BETA. As those transmembrane receptors of the TGF-beta superfamily (RECEPTORS, TRANSFORMING GROWTH FACTOR BETA), ALK's consist of two different but related protein kinases, Type I and Type II. Activins initiate cellular signal transduction by first binding to the type II receptors (ACTIVIN RECEPTORS, TYPE II ) which then recruit and phosphorylate the type I receptors (ACTIVIN RECEPTORS, TYPE I ) with subsequent activation of the type I kinase activity.
A negative regulator of BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS that blocks activation of CYCLIN-DEPENDENT KINASE INHIBITOR P16 and is de-regulated in a variety of NEOPLASMS.
Transport proteins that carry specific substances in the blood or across cell membranes.
A family of smad proteins that undergo PHOSPHORYLATION by CELL SURFACE RECEPTORS in response to TRANSFORMING GROWTH FACTOR BETA; ACTIVIN; or BONE MORPHOGENETIC PROTEIN signaling.
A technique that localizes specific nucleic acid sequences within intact chromosomes, eukaryotic cells, or bacterial cells through the use of specific nucleic acid-labeled probes.
An enzyme that catalyzes the conversion of an orthophosphoric monoester and water to an alcohol and orthophosphate. EC 3.1.3.1.
A family of metalloproteases that are related to the DROSOPHILA protein tolloid, which is a gene product necessary for dorsal-ventral patterning in early Drosophila embryogenesis. Many members of the group may play a significant role in intercellular signaling.
Diffusible gene products that act on homologous or heterologous molecules of viral or cellular DNA to regulate the expression of proteins.
The grafting of bone from a donor site to a recipient site.
A homeodomain protein that interacts with TATA-BOX BINDING PROTEIN. It represses GENETIC TRANSCRIPTION of target GENES and plays a critical role in ODONTOGENESIS.
Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein.
Proteins obtained from various species of Xenopus. Included here are proteins from the African clawed frog (XENOPUS LAEVIS). Many of these proteins have been the subject of scientific investigations in the area of MORPHOGENESIS and development.
The development of bony substance in normally soft structures.
A transcription factor that dimerizes with CORE BINDING FACTOR BETA SUBUNIT to form core binding factor. It contains a highly conserved DNA-binding domain known as the runt domain and is involved in genetic regulation of skeletal development and CELL DIFFERENTIATION.
The formation of cartilage. This process is directed by CHONDROCYTES which continually divide and lay down matrix during development. It is sometimes a precursor to OSTEOGENESIS.
Relatively undifferentiated cells that retain the ability to divide and proliferate throughout postnatal life to provide progenitor cells that can differentiate into specialized cells.
RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm.
Process by which organic tissue becomes hardened by the physiologic deposit of calcium salts.
Increased VASCULAR RESISTANCE in the PULMONARY CIRCULATION, usually secondary to HEART DISEASES or LUNG DISEASES.
A variation of the PCR technique in which cDNA is made from RNA via reverse transcription. The resultant cDNA is then amplified using standard PCR protocols.
A disease characterized by bony deposits or the ossification of muscle tissue.
An inhibitory smad protein that associates with TRANSFORMING GROWTH FACTOR BETA RECEPTORS and BONE MORPHOGENETIC PROTEIN RECEPTORS. It negatively regulates SIGNAL TRANSDUCTION PATHWAYS by inhibiting PHOSPHORYLATION of RECEPTOR-REGULATED SMAD PROTEINS.
A family of intercellular signaling proteins that play and important role in regulating the development of many TISSUES and organs. Their name derives from the observation of a hedgehog-like appearance in DROSOPHILA embryos with genetic mutations that block their action.
Synthetic or natural materials for the replacement of bones or bone tissue. They include hard tissue replacement polymers, natural coral, hydroxyapatite, beta-tricalcium phosphate, and various other biomaterials. The bone substitutes as inert materials can be incorporated into surrounding tissue or gradually replaced by original tissue.
Wnt proteins are a large family of secreted glycoproteins that play essential roles in EMBRYONIC AND FETAL DEVELOPMENT, and tissue maintenance. They bind to FRIZZLED RECEPTORS and act as PARACRINE PROTEIN FACTORS to initiate a variety of SIGNAL TRANSDUCTION PATHWAYS. The canonical Wnt signaling pathway stabilizes the transcriptional coactivator BETA CATENIN.
Forms of hepcidin, a cationic amphipathic peptide synthesized in the liver as a prepropeptide which is first processed into prohepcidin and then into the biologically active hepcidin forms, including in human the 20-, 22-, and 25-amino acid residue peptide forms. Hepcidin acts as a homeostatic regulators of iron metabolism and also possesses antimicrobial activity.
Polymorphic cells that form cartilage.
Proteins encoded by homeobox genes (GENES, HOMEOBOX) that exhibit structural similarity to certain prokaryotic and eukaryotic DNA-binding proteins. Homeodomain proteins are involved in the control of gene expression during morphogenesis and development (GENE EXPRESSION REGULATION, DEVELOPMENTAL).
Vitamin K-dependent calcium-binding protein synthesized by OSTEOBLASTS and found primarily in BONES. Serum osteocalcin measurements provide a noninvasive specific marker of bone metabolism. The protein contains three residues of the amino acid gamma-carboxyglutamic acid (Gla), which, in the presence of CALCIUM, promotes binding to HYDROXYAPATITE and subsequent accumulation in BONE MATRIX.
The developmental entity of a fertilized chicken egg (ZYGOTE). The developmental process begins about 24 h before the egg is laid at the BLASTODISC, a small whitish spot on the surface of the EGG YOLK. After 21 days of incubation, the embryo is fully developed before hatching.
All of the processes involved in increasing CELL NUMBER including CELL DIVISION.
Established cell cultures that have the potential to propagate indefinitely.
The outer of the three germ layers of an embryo.
The development of anatomical structures to create the form of a single- or multi-cell organism. Morphogenesis provides form changes of a part, parts, or the whole organism.
A non-vascular form of connective tissue composed of CHONDROCYTES embedded in a matrix that includes CHONDROITIN SULFATE and various types of FIBRILLAR COLLAGEN. There are three major types: HYALINE CARTILAGE; FIBROCARTILAGE; and ELASTIC CARTILAGE.
The developmental history of specific differentiated cell types as traced back to the original STEM CELLS in the embryo.
Endogenous substances, usually proteins, which are effective in the initiation, stimulation, or termination of the genetic transcription process.
The SKELETON of the HEAD including the FACIAL BONES and the bones enclosing the BRAIN.
The developmental entity of a fertilized egg (ZYGOTE) in animal species other than MAMMALS. For chickens, use CHICK EMBRYO.
Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation.
Proteins which bind to DNA. The family includes proteins which bind to both double- and single-stranded DNA and also includes specific DNA binding proteins in serum which can be used as markers for malignant diseases.
A Wnt protein subtype that plays a role in cell-cell signaling during EMBRYONIC DEVELOPMENT and the morphogenesis of the developing NEURAL TUBE.
Proteins obtained from the ZEBRAFISH. Many of the proteins in this species have been the subject of studies involving basic embryological development (EMBRYOLOGY).
Bone-marrow-derived, non-hematopoietic cells that support HEMATOPOETIC STEM CELLS. They have also been isolated from other organs and tissues such as UMBILICAL CORD BLOOD, umbilical vein subendothelium, and WHARTON JELLY. These cells are considered to be a source of multipotent stem cells because they include subpopulations of mesenchymal stem cells.
Proteins prepared by recombinant DNA technology.
Cell-surface proteins that bind transforming growth factor beta and trigger changes influencing the behavior of cells. Two types of transforming growth factor receptors have been recognized. They differ in affinity for different members of the transforming growth factor beta family and in cellular mechanisms of action.
Breaks in bones.
Strains of mice in which certain GENES of their GENOMES have been disrupted, or "knocked-out". To produce knockouts, using RECOMBINANT DNA technology, the normal DNA sequence of the gene being studied is altered to prevent synthesis of a normal gene product. Cloned cells in which this DNA alteration is successful are then injected into mouse EMBRYOS to produce chimeric mice. The chimeric mice are then bred to yield a strain in which all the cells of the mouse contain the disrupted gene. Knockout mice are used as EXPERIMENTAL ANIMAL MODELS for diseases (DISEASE MODELS, ANIMAL) and to clarify the functions of the genes.
The entity of a developing mammal (MAMMALS), generally from the cleavage of a ZYGOTE to the end of embryonic differentiation of basic structures. For the human embryo, this represents the first two months of intrauterine development preceding the stages of the FETUS.
A Wnt protein subtype that plays a role in cell-cell signaling during EMBRYONIC DEVELOPMENT and the morphogenesis of the developing NEURAL TUBE. Defects in Wnt3 protein are associated with autosomal recessive tetra-AMELIA in humans.
Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories.
An exotic species of the family CYPRINIDAE, originally from Asia, that has been introduced in North America. They are used in embryological studies and to study the effects of certain chemicals on development.
Histochemical localization of immunoreactive substances using labeled antibodies as reagents.
Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN.
The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment.
The transference of BONE MARROW from one human or animal to another for a variety of purposes including HEMATOPOIETIC STEM CELL TRANSPLANTATION or MESENCHYMAL STEM CELL TRANSPLANTATION.
The phenotypic manifestation of a gene or genes by the processes of GENETIC TRANSCRIPTION and GENETIC TRANSLATION.
A receptor-regulated smad protein that undergoes PHOSPHORYLATION by ACTIVIN RECEPTORS, TYPE I. It regulates TRANSFORMING GROWTH FACTOR BETA and ACTIVIN signaling.
Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations.
A group of enzymes that catalyzes the phosphorylation of serine or threonine residues in proteins, with ATP or other nucleotides as phosphate donors.
A family of small polypeptide growth factors that share several common features including a strong affinity for HEPARIN, and a central barrel-shaped core region of 140 amino acids that is highly homologous between family members. Although originally studied as proteins that stimulate the growth of fibroblasts this distinction is no longer a requirement for membership in the fibroblast growth factor family.
The physiological restoration of bone tissue and function after a fracture. It includes BONY CALLUS formation and normal replacement of bone tissue.
Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment.
Thin outer membrane that surrounds a bone. It contains CONNECTIVE TISSUE, CAPILLARIES, nerves, and a number of cell types.
The two longitudinal ridges along the PRIMITIVE STREAK appearing near the end of GASTRULATION during development of nervous system (NEURULATION). The ridges are formed by folding of NEURAL PLATE. Between the ridges is a neural groove which deepens as the fold become elevated. When the folds meet at midline, the groove becomes a closed tube, the NEURAL TUBE.
The founding member of the nodal signaling ligand family of proteins. Nodal protein was originally discovered in the region of the mouse embryo primitive streak referred to as HENSEN'S NODE. It is expressed asymmetrically on the left side in chordates and plays a critical role in the genesis of left-right asymmetry during vertebrate development.
X-RAY COMPUTERIZED TOMOGRAPHY with resolution in the micrometer range.
The short wide vessel arising from the conus arteriosus of the right ventricle and conveying unaerated blood to the lungs.
The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments.
Signal molecules that are involved in the control of cell growth and differentiation.
Cells derived from the BLASTOCYST INNER CELL MASS which forms before implantation in the uterine wall. They retain the ability to divide, proliferate and provide progenitor cells that can differentiate into specialized cells.
Identification of proteins or peptides that have been electrophoretically separated by blot transferring from the electrophoresis gel to strips of nitrocellulose paper, followed by labeling with antibody probes.
The developmental stage that follows BLASTULA or BLASTOCYST. It is characterized by the morphogenetic cell movements including invagination, ingression, and involution. Gastrulation begins with the formation of the PRIMITIVE STREAK, and ends with the formation of three GERM LAYERS, the body plan of the mature organism.
The longest and largest bone of the skeleton, it is situated between the hip and the knee.
The complex processes of initiating CELL DIFFERENTIATION in the embryo. The precise regulation by cell interactions leads to diversity of cell types and specific pattern of organization (EMBRYOGENESIS).
An aquatic genus of the family, Pipidae, occurring in Africa and distinguished by having black horny claws on three inner hind toes.
Conjugated protein-carbohydrate compounds including mucins, mucoid, and amyloid glycoproteins.
The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence.
Elements of limited time intervals, contributing to particular results or situations.
The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION.
Congenital structural deformities of the upper and lower extremities collectively or unspecified.
Glycoproteins that inhibit pituitary FOLLICLE STIMULATING HORMONE secretion. Inhibins are secreted by the Sertoli cells of the testes, the granulosa cells of the ovarian follicles, the placenta, and other tissues. Inhibins and ACTIVINS are modulators of FOLLICLE STIMULATING HORMONE secretions; both groups belong to the TGF-beta superfamily, as the TRANSFORMING GROWTH FACTOR BETA. Inhibins consist of a disulfide-linked heterodimer with a unique alpha linked to either a beta A or a beta B subunit to form inhibin A or inhibin B, respectively
Supporting cells for the developing female gamete in the OVARY. They are derived from the coelomic epithelial cells of the gonadal ridge. Granulosa cells form a single layer around the OOCYTE in the primordial ovarian follicle and advance to form a multilayered cumulus oophorus surrounding the OVUM in the Graafian follicle. The major functions of granulosa cells include the production of steroids and LH receptors (RECEPTORS, LH).
Small cationic peptides that are an important component, in most species, of early innate and induced defenses against invading microbes. In animals they are found on mucosal surfaces, within phagocytic granules, and on the surface of the body. They are also found in insects and plants. Among others, this group includes the DEFENSINS, protegrins, tachyplesins, and thionins. They displace DIVALENT CATIONS from phosphate groups of MEMBRANE LIPIDS leading to disruption of the membrane.
Cell surface proteins that bind signalling molecules external to the cell with high affinity and convert this extracellular event into one or more intracellular signals that alter the behavior of the target cell (From Alberts, Molecular Biology of the Cell, 2nd ed, pp693-5). Cell surface receptors, unlike enzymes, do not chemically alter their ligands.
Formation of differentiated cells and complicated tissue organization to provide specialized functions.
A large multinuclear cell associated with the BONE RESORPTION. An odontoclast, also called cementoclast, is cytomorphologically the same as an osteoclast and is involved in CEMENTUM resorption.
The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety.
Macromolecular organic compounds that contain carbon, hydrogen, oxygen, nitrogen, and usually, sulfur. These macromolecules (proteins) form an intricate meshwork in which cells are embedded to construct tissues. Variations in the relative types of macromolecules and their organization determine the type of extracellular matrix, each adapted to the functional requirements of the tissue. The two main classes of macromolecules that form the extracellular matrix are: glycosaminoglycans, usually linked to proteins (proteoglycans), and fibrous proteins (e.g., COLLAGEN; ELASTIN; FIBRONECTINS; and LAMININ).
The farthest or outermost projections of the body, such as the HAND and FOOT.
They are glycopeptides and subunits in INHIBINS and ACTIVINS. Inhibins and activins belong to the transforming growth factor beta superfamily.
A subtype of transforming growth factor beta that is synthesized by a wide variety of cells. It is synthesized as a precursor molecule that is cleaved to form mature TGF-beta 1 and TGF-beta1 latency-associated peptide. The association of the cleavage products results in the formation a latent protein which must be activated to bind its receptor. Defects in the gene that encodes TGF-beta1 are the cause of CAMURATI-ENGELMANN SYNDROME.
The inner of the three germ layers of an embryo.
A positive regulatory effect on physiological processes at the molecular, cellular, or systemic level. At the molecular level, the major regulatory sites include membrane receptors, genes (GENE EXPRESSION REGULATION), mRNAs (RNA, MESSENGER), and proteins.
Genes whose expression is easily detectable and therefore used to study promoter activity at many positions in a target genome. In recombinant DNA technology, these genes may be attached to a promoter region of interest.
The second longest bone of the skeleton. It is located on the medial side of the lower leg, articulating with the FIBULA laterally, the TALUS distally, and the FEMUR proximally.
The inner and longer bone of the FOREARM.
Removal of mineral constituents or salts from bone or bone tissue. Demineralization is used as a method of studying bone strength and bone chemistry.
Cellular signaling in which a factor secreted by a cell affects other cells in the local environment. This term is often used to denote the action of INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS on surrounding cells.
Short sequences (generally about 10 base pairs) of DNA that are complementary to sequences of messenger RNA and allow reverse transcriptases to start copying the adjacent sequences of mRNA. Primers are used extensively in genetic and molecular biology techniques.
Congenital anomaly of abnormally short fingers or toes.
Inhibitor of differentiation proteins are negative regulators of BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS. They inhibit CELL DIFFERENTIATION and induce CELL PROLIFERATION by modulating different CELL CYCLE regulators.
Proteins that originate from insect species belonging to the genus DROSOPHILA. The proteins from the most intensely studied species of Drosophila, DROSOPHILA MELANOGASTER, are the subject of much interest in the area of MORPHOGENESIS and development.
The biosynthesis of RNA carried out on a template of DNA. The biosynthesis of DNA from an RNA template is called REVERSE TRANSCRIPTION.
Generating tissue in vitro for clinical applications, such as replacing wounded tissues or impaired organs. The use of TISSUE SCAFFOLDING enables the generation of complex multi-layered tissues and tissue structures.
A tube-like invagination of the EPIDERMIS from which the hair shaft develops and into which SEBACEOUS GLANDS open. The hair follicle is lined by a cellular inner and outer root sheath of epidermal origin and is invested with a fibrous sheath derived from the dermis. (Stedman, 26th ed) Follicles of very long hairs extend into the subcutaneous layer of tissue under the SKIN.
A growth differentiation factor that is closely-related in structure to BONE MORPHOGENETIC PROTEIN 3. Growth differentiation factor 10 is found at high levels in BONE, however it plays an additional roles in regulating EMBRYONIC DEVELOPMENT.
A multi-functional catenin that participates in CELL ADHESION and nuclear signaling. Beta catenin binds CADHERINS and helps link their cytoplasmic tails to the ACTIN in the CYTOSKELETON via ALPHA CATENIN. It also serves as a transcriptional co-activator and downstream component of WNT PROTEIN-mediated SIGNAL TRANSDUCTION PATHWAYS.
A negative regulatory effect on physiological processes at the molecular, cellular, or systemic level. At the molecular level, the major regulatory sites include membrane receptors, genes (GENE EXPRESSION REGULATION), mRNAs (RNA, MESSENGER), and proteins.
Naturally occurring or experimentally induced animal diseases with pathological processes sufficiently similar to those of human diseases. They are used as study models for human diseases.
Morphological and physiological development of EMBRYOS.
A cell line derived from cultured tumor cells.
Breaks in CARTILAGE.
Mature osteoblasts that have become embedded in the BONE MATRIX. They occupy a small cavity, called lacuna, in the matrix and are connected to adjacent osteocytes via protoplasmic projections called canaliculi.
The uptake of naked or purified DNA by CELLS, usually meaning the process as it occurs in eukaryotic cells. It is analogous to bacterial transformation (TRANSFORMATION, BACTERIAL) and both are routinely employed in GENE TRANSFER TECHNIQUES.
CELL LINES derived from the CV-1 cell line by transformation with a replication origin defective mutant of SV40 VIRUS, which codes for wild type large T antigen (ANTIGENS, POLYOMAVIRUS TRANSFORMING). They are used for transfection and cloning. (The CV-1 cell line was derived from the kidney of an adult male African green monkey (CERCOPITHECUS AETHIOPS).)
The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION.
A protective layer of firm, flexible cartilage over the articulating ends of bones. It provides a smooth surface for joint movement, protecting the ends of long bones from wear at points of contact.
A SOXE transcription factor that plays a critical role in regulating CHONDROGENESIS; OSTEOGENESIS; and male sex determination. Loss of function of the SOX9 transcription factor due to genetic mutations is a cause of CAMPOMELIC DYSPLASIA.
The reproductive organ (GONADS) in female animals. In vertebrates, the ovary contains two functional parts: the OVARIAN FOLLICLE for the production of female germ cells (OOGENESIS); and the endocrine cells (GRANULOSA CELLS; THECA CELLS; and LUTEAL CELLS) for the production of ESTROGENS and PROGESTERONE.
The most common form of fibrillar collagen. It is a major constituent of bone (BONE AND BONES) and SKIN and consists of a heterotrimer of two alpha1(I) and one alpha2(I) chains.
The process of TOOTH formation. It is divided into several stages including: the dental lamina stage, the bud stage, the cap stage, and the bell stage. Odontogenesis includes the production of tooth enamel (AMELOGENESIS), dentin (DENTINOGENESIS), and dental cementum (CEMENTOGENESIS).
Non-striated, elongated, spindle-shaped cells found lining the digestive tract, uterus, and blood vessels. They are derived from specialized myoblasts (MYOBLASTS, SMOOTH MUSCLE).
Broadly distributed glycoproteins that are homologous to the activin-binding protein, FOLLISTATIN. These follistatin-related proteins are encoded by a number of genes.
DNA sequences which are recognized (directly or indirectly) and bound by a DNA-dependent RNA polymerase during the initiation of transcription. Highly conserved sequences within the promoter include the Pribnow box in bacteria and the TATA BOX in eukaryotes.
One of the mechanisms by which CELL DEATH occurs (compare with NECROSIS and AUTOPHAGOCYTOSIS). Apoptosis is the mechanism responsible for the physiological deletion of cells and appears to be intrinsically programmed. It is characterized by distinctive morphologic changes in the nucleus and cytoplasm, chromatin cleavage at regularly spaced sites, and the endonucleolytic cleavage of genomic DNA; (DNA FRAGMENTATION); at internucleosomal sites. This mode of cell death serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth.
Reduction of bone mass without alteration in the composition of bone, leading to fractures. Primary osteoporosis can be of two major types: postmenopausal osteoporosis (OSTEOPOROSIS, POSTMENOPAUSAL) and age-related or senile osteoporosis.
Connective tissue cells of an organ found in the loose connective tissue. These are most often associated with the uterine mucosa and the ovary as well as the hematopoietic system and elsewhere.
The level of protein structure in which combinations of secondary protein structures (alpha helices, beta sheets, loop regions, and motifs) pack together to form folded shapes called domains. Disulfide bridges between cysteines in two different parts of the polypeptide chain along with other interactions between the chains play a role in the formation and stabilization of tertiary structure. Small proteins usually consist of only one domain but larger proteins may contain a number of domains connected by segments of polypeptide chain which lack regular secondary structure.
A fibroblast growth factor that preferentially activates FIBROBLAST GROWTH FACTOR RECEPTOR 4. It was initially identified as an androgen-induced growth factor and plays a role in regulating growth of human BREAST NEOPLASMS and PROSTATIC NEOPLASMS.
Culture media containing biologically active components obtained from previously cultured cells or tissues that have released into the media substances affecting certain cell functions (e.g., growth, lysis).
A union between adjacent bones or parts of a single bone formed by osseous material, such as ossified connecting cartilage or fibrous tissue. (Dorland, 27th ed)
Pathologic deposition of calcium salts in tissues.
A TGF-beta subtype that plays role in regulating epithelial-mesenchymal interaction during embryonic development. It is synthesized as a precursor molecule that is cleaved to form mature TGF-beta3 and TGF-beta3 latency-associated peptide. The association of the cleavage products results in the formation a latent protein which must be activated to bind its receptor.
A gene silencing phenomenon whereby specific dsRNAs (RNA, DOUBLE-STRANDED) trigger the degradation of homologous mRNA (RNA, MESSENGER). The specific dsRNAs are processed into SMALL INTERFERING RNA (siRNA) which serves as a guide for cleavage of the homologous mRNA in the RNA-INDUCED SILENCING COMPLEX. DNA METHYLATION may also be triggered during this process.
The determination of the pattern of genes expressed at the level of GENETIC TRANSCRIPTION, under specific circumstances or in a specific cell.
The growth action of bone tissue as it assimilates surgically implanted devices or prostheses to be used as either replacement parts (e.g., hip) or as anchors (e.g., endosseous dental implants).
A TGF-beta subtype that was originally identified as a GLIOBLASTOMA-derived factor which inhibits the antigen-dependent growth of both helper and CYTOTOXIC T LYMPHOCYTES. It is synthesized as a precursor molecule that is cleaved to form mature TGF-beta2 and TGF-beta2 latency-associated peptide. The association of the cleavage products results in the formation a latent protein which must be activated to bind its receptor.
The entire nerve apparatus, composed of a central part, the brain and spinal cord, and a peripheral part, the cranial and spinal nerves, autonomic ganglia, and plexuses. (Stedman, 26th ed)
An OOCYTE-containing structure in the cortex of the OVARY. The oocyte is enclosed by a layer of GRANULOSA CELLS providing a nourishing microenvironment (FOLLICULAR FLUID). The number and size of follicles vary depending on the age and reproductive state of the female. The growing follicles are divided into five stages: primary, secondary, tertiary, Graafian, and atretic. Follicular growth and steroidogenesis depend on the presence of GONADOTROPINS.
Proteins which are found in membranes including cellular and intracellular membranes. They consist of two types, peripheral and integral proteins. They include most membrane-associated enzymes, antigenic proteins, transport proteins, and drug, hormone, and lectin receptors.
Either of a pair of compound bones forming the lateral (left and right) surfaces and base of the skull which contains the organs of hearing. It is a large bone formed by the fusion of parts: the squamous (the flattened anterior-superior part), the tympanic (the curved anterior-inferior part), the mastoid (the irregular posterior portion), and the petrous (the part at the base of the skull).
The granulosa cells of the cumulus oophorus which surround the OVUM in the GRAAFIAN FOLLICLE. At OVULATION they are extruded with OVUM.
A receptor-regulated smad protein that undergoes PHOSPHORYLATION by ACTIVIN RECEPTORS, TYPE I. Activated Smad3 can bind directly to DNA, and it regulates TRANSFORMING GROWTH FACTOR BETA and ACTIVIN signaling.
Mice bearing mutant genes which are phenotypically expressed in the animals.
An early embryonic developmental process of CHORDATES that is characterized by morphogenic movements of ECTODERM resulting in the formation of the NEURAL PLATE; the NEURAL CREST; and the NEURAL TUBE. Improper closure of the NEURAL GROOVE results in congenital NEURAL TUBE DEFECTS.
Cell growth support structures composed of BIOCOMPATIBLE MATERIALS. They are specially designed solid support matrices for cell attachment in TISSUE ENGINEERING and GUIDED TISSUE REGENERATION uses.
The region in the dorsal ECTODERM of a chordate embryo that gives rise to the future CENTRAL NERVOUS SYSTEM. Tissue in the neural plate is called the neuroectoderm, often used as a synonym of neural plate.

Ectopic bone morphogenetic proteins 5 and 4 in the chicken forebrain lead to cyclopia and holoprosencephaly. (1/42)

Proper dorsal-ventral patterning in the developing central nervous system requires signals from both the dorsal and ventral portions of the neural tube. Data from multiple studies have demonstrated that bone morphogenetic proteins (BMPs) and Sonic hedgehog protein are secreted factors that regulate dorsal and ventral specification, respectively, within the caudal neural tube. In the developing rostral central nervous system Sonic hedgehog protein also participates in ventral regionalization; however, the roles of BMPs in the developing brain are less clear. We hypothesized that BMPs also play a role in dorsal specification of the vertebrate forebrain. To test our hypothesis we implanted beads soaked in recombinant BMP5 or BMP4 into the neural tube of the chicken forebrain. Experimental embryos showed a loss of the basal telencephalon that resulted in holoprosencephaly (a single cerebral hemisphere), cyclopia (a single midline eye), and loss of ventral midline structures. In situ hybridization using a panel of probes to genes expressed in the dorsal and ventral forebrain revealed the loss of ventral markers with the maintenance of dorsal markers. Furthermore, we found that the loss of the basal telencephalon was the result of excessive cell death and not a change in cell fates. These data provide evidence that BMP signaling participates in dorsal-ventral patterning of the developing brain in vivo, and disturbances in dorsal-ventral signaling result in specific malformations of the forebrain.  (+info)

Early embryonic lethality in Bmp5;Bmp7 double mutant mice suggests functional redundancy within the 60A subgroup. (2/42)

Members of the BMP family of signaling molecules display a high conservation of structure and function, and multiple BMPs are often coexpressed in a variety of tissues during development. Moreover, distinct BMP ligands are capable of activating common pathways. Here we describe the coexpression of two members of the 60A subfamily of BMPs, Bmp5 and Bmp7, at a number of different sites in the embryo from gastrulation onwards. Previous studies demonstrate that loss of either Bmp5 or Bmp7 has negligible effects on development, suggesting these molecules functionally compensate for each other at early stages of embryonic development. Here we show this is indeed the case. Thus we find that Bmp5;Bmp7 double mutants die at 10.5 dpc and display striking defects primarily affecting the tissues where these factors are coexpressed. The present analysis also uncovers novel roles for BMP signaling during the development of the allantois, heart, branchial arches, somites and forebrain. Bmp5 and Bmp7 do not appear to be involved in establishing pattern in these tissues, but are instead necessary for the proliferation and maintenance of specific cell populations. These findings are discussed with respect to potential mechanisms underlying cooperative signaling by multiple members of the TGF-beta superfamily.  (+info)

Molecular characterization and phylogenetic analysis of SpBMP5-7, a new member of the TGF-beta superfamily expressed in sea urchin embryos. (3/42)

TGF-beta ligands are probably pan-bilaterian in phylogenetic distribution. The family appears to have diversified greatly with the evolution of the vertebrates, but only a few invertebrate deuterostome TGF-beta molecules have so far been isolated. A search for members of this family expressed in sea urchin embryos, using canonical PCR primers, revealed a single-copy gene encoding a new TGF-beta protein. The sequence which it encodes is closely related to those of vertebrate bone morphogenetic proteins (BMPs) 5-7. No additional TGF-beta family members were uncovered other than univin, which had previously been reported.  (+info)

Efficient studies of long-distance Bmp5 gene regulation using bacterial artificial chromosomes. (4/42)

The regulatory regions surrounding many genes may be large and difficult to study using standard transgenic approaches. Here we describe the use of bacterial artificial chromosome clones to rapidly survey hundreds of kilobases of DNA for potential regulatory sequences surrounding the mouse bone morphogenetic protein-5 (Bmp5) gene. Simple coinjection of large insert clones with lacZ reporter constructs recapitulates all of the sites of expression observed previously with numerous small constructs covering a large, complex regulatory region. The coinjection approach has made it possible to rapidly survey other regions of the Bmp5 gene for potential control elements, to confirm the location of several elements predicted from previous expression studies using regulatory mutations at the Bmp5 locus, to test whether Bmp5 control regions act similarly on endogenous and foreign promoters, and to show that Bmp5 control elements are capable of rescuing phenotypic effects of a Bmp5 deficiency. This rapid approach has identified new Bmp5 control regions responsible for controlling the development of specific anatomical structures in the vertebrate skeleton. A similar approach may be useful for studying complex control regions surrounding many other genes important in embryonic development and human disease.  (+info)

Bone morphogenetic protein-5 (BMP-5) promotes dendritic growth in cultured sympathetic neurons. (5/42)

BACKGROUND: BMP-5 is expressed in the nervous system throughout development and into adulthood. However its effects on neural tissues are not well defined. BMP-5 is a member of the 60A subgroup of BMPs, other members of which have been shown to stimulate dendritic growth in central and peripheral neurons. We therefore examined the possibility that BMP-5 similarly enhances dendritic growth in cultured sympathetic neurons. RESULTS: Sympathetic neurons cultured in the absence of serum or glial cells do not form dendrites; however, addition of BMP-5 causes these neurons to extend multiple dendritic processes, which is preceded by an increase in phosphorylation of the Smad-1 transcription factor. The dendrite-promoting activity of BMP-5 is significantly inhibited by the BMP antagonists noggin and follistatin and by a BMPR-IA-Fc chimeric protein. RT-PCR and immunocytochemical analyses indicate that BMP-5 mRNA and protein are expressed in the superior cervical ganglia (SCG) during times of initial growth and rapid expansion of the dendritic arbor. CONCLUSIONS: These data suggest a role for BMP-5 in regulating dendritic growth in sympathetic neurons. The signaling pathway that mediates the dendrite-promoting activity of BMP-5 may involve binding to BMPR-IA and activation of Smad-1, and relative levels of BMP antagonists such as noggin and follistatin may modulate BMP-5 signaling. Since BMP-5 is expressed at relatively high levels not only in the developing but also the adult nervous system, these findings suggest the possibility that BMP-5 regulates dendritic morphology not only in the developing, but also the adult nervous system.  (+info)

Expression of bone morphogenetic protein-5 gene during chick heart development: possible roles in valvuloseptal endocardial cushion formation. (6/42)

The bone morphogenetic protein (BMP) family, comprising multifunctional peptide growth factors, regulates many developmental processes in a variety of tissues. We examined the spatiotemporal expression of BMP5 by in situ hybridization in chick embryonic hearts from stages 5 to 33. The BMP5 gene was first expressed in the endoderm underlying the precardiac mesoderm at stages 5 to 8. Thereafter, BMP5 expression was restricted to the myocardium of the atrioventricular (AV) canal and outflow tract (OT) regions, where the valvuloseptal endocardial cushion tissue is induced. These results suggest that BMP5 may play important roles not only in myocardial differentiation, but also in the formation and maintenance of endocardial cushion tissue.  (+info)

Bone morphogenetic proteins promote cartilage differentiation and protect engineered artificial cartilage from fibroblast invasion and destruction. (7/42)

OBJECTIVE: An important role in joint and cartilage homeostasis in adults has been demonstrated recently for morphogenetic factors of the transforming growth factor beta family. Therefore, this study was undertaken to investigate the potential of bone morphogenetic proteins (BMPs) in chondrocyte differentiation using current technologies of tissue engineering. METHODS: Complementary DNAs of recombinant human BMPs 2, 4, 5, 6, and 7 were transfected into primary bovine articular chondrocytes. Transgenic chondrocytes were assembled 3-dimensionally in alginate or in bioresorbable co-polymer fleeces of vicryl and polydioxanon embedded in low-melting-point agarose. Redifferentiation and formation of cartilage tissue in vitro or after subcutaneous transplantation into nude mice were assayed by semiquantitative reverse transcriptase-polymerase chain reaction, histology, and in situ hybridization, and findings were compared with those in unmodified or control-transfected primary chondrocytes. RESULTS: Compared with other BMPs and control vector, BMP-7 induced a decrease in type I collagen expression in artificial cartilage, while transcription of the cartilage-specific type II collagen remained stable. In transplantation experiments, BMP-7 transgenic cartilage revealed the greatest amount of matrix synthesis, and BMP-7 was the only morphogen to suppress the infiltrative response of mouse fibroblastic cells into engineered cartilage, thereby preventing transplant destruction. CONCLUSION: Cartilage differentiation and matrix maturation are promoted by BMPs in cartilage engineering. The inhibitory effect of BMP-7 on a nonspecific infiltrative response in immunocompromised nude mice further suggests that individual morphogens not only may contribute to cartilage maturation, but also may protect it from nonspecific inflammation and invasive destruction. These properties advance BMPs as promising tools for engineering of cartilaginous joint bioprostheses and as candidate biologic agents or genes for cartilage stabilization in arthritis.  (+info)

The specification of noradrenergic locus coeruleus (LC) neurones depends on bone morphogenetic proteins (BMPs). (8/42)

The role of BMPs in the development of the major noradrenergic centre of the brain, the locus coeruleus (LC), was investigated. LC generation is reflected by initial expression of the transcription factors Phox2a and Phox2b in dorsal rhombomere1 (r1), followed by expression of dopamine-beta-hydroxylase and tyrosine hydroxylase. Bmp5 is expressed in the dorsal neuroepithelium in proximity to Phox2-expressing cells. BMP inhibition in stage 10 chick embryos resulted in the lack of LC neurones or in their generation at the dorsal midline, and loss of roof plate and rhombic lip, but it did not affect neural crest development. These results reveal late essential BMP functions in the specification of dorsal neuronal phenotypes in r1, including LC neurones, and in the development of dorsal midline structures.  (+info)

There are several factors that can contribute to bone resorption, including:

1. Hormonal changes: Hormones such as parathyroid hormone (PTH) and calcitonin can regulate bone resorption. Imbalances in these hormones can lead to excessive bone resorption.
2. Aging: As we age, our bones undergo remodeling more frequently, leading to increased bone resorption.
3. Nutrient deficiencies: Deficiencies in calcium, vitamin D, and other nutrients can impair bone health and lead to excessive bone resorption.
4. Inflammation: Chronic inflammation can increase bone resorption, leading to bone loss and weakening.
5. Genetics: Some genetic disorders can affect bone metabolism and lead to abnormal bone resorption.
6. Medications: Certain medications, such as glucocorticoids and anticonvulsants, can increase bone resorption.
7. Diseases: Conditions such as osteoporosis, Paget's disease of bone, and bone cancer can lead to abnormal bone resorption.

Bone resorption can be diagnosed through a range of tests, including:

1. Bone mineral density (BMD) testing: This test measures the density of bone in specific areas of the body. Low BMD can indicate bone loss and excessive bone resorption.
2. X-rays and imaging studies: These tests can help identify abnormal bone growth or other signs of bone resorption.
3. Blood tests: Blood tests can measure levels of certain hormones and nutrients that are involved in bone metabolism.
4. Bone biopsy: A bone biopsy can provide a direct view of the bone tissue and help diagnose conditions such as Paget's disease or bone cancer.

Treatment for bone resorption depends on the underlying cause and may include:

1. Medications: Bisphosphonates, hormone therapy, and other medications can help slow or stop bone resorption.
2. Diet and exercise: A healthy diet rich in calcium and vitamin D, along with regular exercise, can help maintain strong bones.
3. Physical therapy: In some cases, physical therapy may be recommended to improve bone strength and mobility.
4. Surgery: In severe cases of bone resorption, surgery may be necessary to repair or replace damaged bone tissue.

Some common types of bone neoplasms include:

* Osteochondromas: These are benign tumors that grow on the surface of a bone.
* Giant cell tumors: These are benign tumors that can occur in any bone of the body.
* Chondromyxoid fibromas: These are rare, benign tumors that develop in the cartilage of a bone.
* Ewing's sarcoma: This is a malignant tumor that usually occurs in the long bones of the arms and legs.
* Multiple myeloma: This is a type of cancer that affects the plasma cells in the bone marrow.

Symptoms of bone neoplasms can include pain, swelling, or deformity of the affected bone, as well as weakness or fatigue. Treatment options depend on the type and location of the tumor, as well as the severity of the symptoms. Treatment may involve surgery, radiation therapy, chemotherapy, or a combination of these.

Some common types of bone diseases include:

1. Osteoporosis: A condition characterized by brittle, porous bones that are prone to fracture.
2. Osteoarthritis: A degenerative joint disease that causes pain and stiffness in the joints.
3. Rheumatoid arthritis: An autoimmune disorder that causes inflammation and pain in the joints.
4. Bone cancer: A malignant tumor that develops in the bones.
5. Paget's disease of bone: A condition characterized by abnormal bone growth and deformity.
6. Osteogenesis imperfecta: A genetic disorder that affects the formation of bone and can cause brittle bones and other skeletal deformities.
7. Fibrous dysplasia: A rare condition characterized by abnormal growth and development of bone tissue.
8. Multiple myeloma: A type of cancer that affects the plasma cells in the bone marrow.
9. Bone cysts: Fluid-filled cavities that can form in the bones and cause pain, weakness, and deformity.
10. Bone spurs: Abnormal growths of bone that can form along the edges of joints and cause pain and stiffness.

Bone diseases can be diagnosed through a variety of tests, including X-rays, CT scans, MRI scans, and bone biopsies. Treatment options vary depending on the specific disease and can include medication, surgery, or a combination of both.

Heterotopic ossification can cause a range of symptoms depending on its location and severity, including pain, stiffness, limited mobility, and difficulty moving the affected limb or joint. Treatment options for heterotopic ossification include medications to reduce inflammation and pain, physical therapy to maintain range of motion, and in severe cases, surgical removal of the abnormal bone growth.

In medical imaging, heterotopic ossification is often diagnosed using X-rays or other imaging techniques such as CT or MRI scans. These tests can help identify the presence of bone growth in an abnormal location and determine the extent of the condition.

Overall, heterotopic ossification is a relatively rare condition that can have a significant impact on a person's quality of life if left untreated. Prompt medical attention and appropriate treatment can help manage symptoms and prevent long-term complications.

Example Sentence: The patient was diagnosed with pulmonary hypertension and began treatment with medication to lower her blood pressure and improve her symptoms.

Word class: Noun phrase / medical condition

The exact cause of myositis ossificans is not fully understood, but it is thought to be related to an abnormal repair process within the muscle tissue. The condition can be diagnosed through a combination of physical examination, imaging studies such as X-rays or MRIs, and biopsy.

Treatment for myositis ossificans usually focuses on relieving pain and improving mobility. This may include rest, physical therapy, anti-inflammatory medications, and in some cases, surgery to remove the abnormal bone growth. The condition can take several months to resolve, and in rare cases, it may recur.

Myositis ossificans is a relatively rare condition, but it can have a significant impact on an individual's quality of life, particularly if left untreated. It is important for healthcare providers to be aware of this condition and its symptoms in order to provide accurate diagnosis and appropriate treatment.

Sources:

* American Academy of Orthopaedic Surgeons. (2019). Myositis Ossificans. Retrieved from
* MedlinePlus. (2020). Myositis ossificans. Retrieved from
* UW Health. (n.d.). Myositis Ossificans. Retrieved from

Open fracture: The bone breaks through the skin, exposing the bone to the outside environment.

Closed fracture: The bone breaks, but does not penetrate the skin.

Comminuted fracture: The bone is broken into many pieces.

Hairline fracture: A thin crack in the bone that does not fully break it.

Non-displaced fracture: The bone is broken, but remains in its normal position.

Displaced fracture: The bone is broken and out of its normal position.

Stress fracture: A small crack in the bone caused by repetitive stress or overuse.

* Osteogenesis imperfecta (OI): A genetic disorder that affects the formation of bone tissue, leading to fragile bones and an increased risk of fractures.
* Rickets: A vitamin D-deficient disease that causes softening of the bones in children.
* Osteomalacia: A condition similar to rickets, but affecting adults and caused by a deficiency of vitamin D or calcium.
* Hyperparathyroidism: A condition in which the parathyroid glands produce too much parathyroid hormone (PTH), leading to an imbalance in bone metabolism and an increase in bone resorption.
* Hypoparathyroidism: A condition in which the parathyroid glands produce too little PTH, leading to low levels of calcium and vitamin D and an increased risk of osteoporosis.

Bone diseases, metabolic are typically diagnosed through a combination of physical examination, imaging studies such as X-rays or CT scans, and laboratory tests to evaluate bone metabolism. Treatment depends on the specific underlying cause of the disease and may include medications, dietary changes, or surgery.

Note: The medical information provided here is for general purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment. If you suspect that your child may have a congenital limb deformity, it is important to consult with a qualified healthcare provider as soon as possible.

There are two types of brachydactyly:

1. Postaxial brachydactyly: This type affects the little finger side of the hand, causing the corresponding finger to be shorter than the others.
2. Preaxial brachydactyly: This type affects the thumb side of the hand, causing the corresponding finger to be shorter than the others.

Brachydactyly can be caused by a variety of genetic mutations or chromosomal abnormalities, such as Turner syndrome, Noonan syndrome, and Down syndrome. It can also be caused by environmental factors, such as maternal diabetes during pregnancy.

The symptoms of brachydactyly may include:

* Shortened fingers or toes
* Limited range of motion in the affected digits
* Difficulty grasping or manipulating objects
* Aesthetic concerns

Treatment for brachydactyly depends on the underlying cause and severity of the condition. In some cases, surgery may be necessary to lengthen the affected fingers or toes. Physical therapy and occupational therapy can also help improve range of motion and function.

It's important to note that brachydactyly is usually a congenital condition, meaning it is present at birth. However, in some cases, it may not be diagnosed until later in childhood or adulthood. If you suspect your child or yourself may have brachydactyly, it's important to consult with a healthcare professional for proper evaluation and treatment.

1) They share similarities with humans: Many animal species share similar biological and physiological characteristics with humans, making them useful for studying human diseases. For example, mice and rats are often used to study diseases such as diabetes, heart disease, and cancer because they have similar metabolic and cardiovascular systems to humans.

2) They can be genetically manipulated: Animal disease models can be genetically engineered to develop specific diseases or to model human genetic disorders. This allows researchers to study the progression of the disease and test potential treatments in a controlled environment.

3) They can be used to test drugs and therapies: Before new drugs or therapies are tested in humans, they are often first tested in animal models of disease. This allows researchers to assess the safety and efficacy of the treatment before moving on to human clinical trials.

4) They can provide insights into disease mechanisms: Studying disease models in animals can provide valuable insights into the underlying mechanisms of a particular disease. This information can then be used to develop new treatments or improve existing ones.

5) Reduces the need for human testing: Using animal disease models reduces the need for human testing, which can be time-consuming, expensive, and ethically challenging. However, it is important to note that animal models are not perfect substitutes for human subjects, and results obtained from animal studies may not always translate to humans.

6) They can be used to study infectious diseases: Animal disease models can be used to study infectious diseases such as HIV, TB, and malaria. These models allow researchers to understand how the disease is transmitted, how it progresses, and how it responds to treatment.

7) They can be used to study complex diseases: Animal disease models can be used to study complex diseases such as cancer, diabetes, and heart disease. These models allow researchers to understand the underlying mechanisms of the disease and test potential treatments.

8) They are cost-effective: Animal disease models are often less expensive than human clinical trials, making them a cost-effective way to conduct research.

9) They can be used to study drug delivery: Animal disease models can be used to study drug delivery and pharmacokinetics, which is important for developing new drugs and drug delivery systems.

10) They can be used to study aging: Animal disease models can be used to study the aging process and age-related diseases such as Alzheimer's and Parkinson's. This allows researchers to understand how aging contributes to disease and develop potential treatments.

There are different types of fractures that can occur in cartilage, including:

1. Fissure fractures: These are small cracks or splits in the cartilage.
2. Fracture-linear fractures: These are longer, more linear cracks in the cartilage.
3. Fracture-bucket handle fractures: These are fractures that have a central crack with two smaller cracks radiating from it, resembling a bucket handle.
4. Fracture-segmental fractures: These are fractures that involve the entire thickness of the cartilage and can be complete or incomplete.

Fractures, cartilage can be caused by a variety of factors, including trauma, sports injuries, degenerative conditions such as osteoarthritis, and systemic diseases such as rheumatoid arthritis. Symptoms of fractures, cartilage can include pain, stiffness, limited mobility, and locking or catching sensations in the affected joint.

Diagnosis of fractures, cartilage is typically made through a combination of physical examination, imaging studies such as X-rays, CT scans, and MRI, and arthroscopy, which involves inserting a small camera into the joint to visualize the cartilage directly.

Treatment for fractures, cartilage depends on the severity of the injury and can include conservative measures such as rest, physical therapy, and medication, or surgical interventions such as repair or replacement of the damaged cartilage. In severe cases, fractures, cartilage may require joint fusion or replacement with an artificial joint.

There are several types of osteoporosis, including:

1. Postmenopausal osteoporosis: This type of osteoporosis is caused by hormonal changes that occur during menopause. It is the most common form of osteoporosis and affects women more than men.
2. Senile osteoporosis: This type of osteoporosis is caused by aging and is the most common form of osteoporosis in older adults.
3. Juvenile osteoporosis: This type of osteoporosis affects children and young adults and can be caused by a variety of genetic disorders or other medical conditions.
4. secondary osteoporosis: This type of osteoporosis is caused by other medical conditions, such as rheumatoid arthritis, Crohn's disease, or ulcerative colitis.

The symptoms of osteoporosis can be subtle and may not appear until a fracture has occurred. They can include:

1. Back pain or loss of height
2. A stooped posture
3. Fractures, especially in the spine, hips, or wrists
4. Loss of bone density, as determined by a bone density test

The diagnosis of osteoporosis is typically made through a combination of physical examination, medical history, and imaging tests, such as X-rays or bone density tests. Treatment for osteoporosis can include medications, such as bisphosphonates, hormone therapy, or rANK ligand inhibitors, as well as lifestyle changes, such as regular exercise and a balanced diet.

Preventing osteoporosis is important, as it can help to reduce the risk of fractures and other complications. To prevent osteoporosis, individuals can:

1. Get enough calcium and vitamin D throughout their lives
2. Exercise regularly, especially weight-bearing activities such as walking or running
3. Avoid smoking and excessive alcohol consumption
4. Maintain a healthy body weight
5. Consider taking medications to prevent osteoporosis, such as bisphosphonates, if recommended by a healthcare provider.

1. Skull deformities: Synostosis can lead to abnormal growth and shape of the skull, which can cause visual disturbances, hearing loss, and other complications.
2. Respiratory problems: Fused bones in the skull can reduce the size of the nasal passages and sinuses, making it harder to breathe properly.
3. Neurological issues: Synostosis can press on the brain and spinal cord, leading to headaches, seizures, and other neurological symptoms.
4. Vision problems: The fusion of bones can cause double vision or other visual disturbances, which can affect a child's ability to learn and develop normally.
5. Hearing loss: In some cases, synostosis can lead to hearing loss due to the abnormal growth of the bones in the middle ear.
6. Sleep apnea: Synostosis can cause the airway to be narrowed or blocked, leading to sleep apnea and other breathing problems.
7. Dental problems: Fused bones in the skull can affect the alignment of teeth and lead to dental problems such as crowding, misalignment, or tooth loss.
8. Speech difficulties: Synostosis can cause speech difficulties due to the abnormal growth of the bones in the mouth and throat.
9. Feeding difficulties: Fused bones in the skull can make it harder for a child to eat properly, leading to feeding difficulties and malnutrition.
10. Emotional and social challenges: Children with synostosis may experience emotional and social challenges due to their appearance or difficulty with basic functions such as eating and breathing.

Treatment for synostosis usually involves a combination of surgery, physical therapy, and other supportive care to help manage the symptoms and improve quality of life.

There are several different types of calcinosis, each with its own unique causes and symptoms. Some common forms of calcinosis include:

1. Dystrophic calcinosis: This type of calcinosis occurs in people with muscular dystrophy, a group of genetic disorders that affect muscle strength and function. Dystrophic calcinosis can cause calcium deposits to form in the muscles, leading to muscle weakness and wasting.
2. Metastatic calcinosis: This type of calcinosis occurs when cancer cells spread to other parts of the body and cause calcium deposits to form. Metastatic calcinosis can occur in people with a variety of different types of cancer, including breast, lung, and prostate cancer.
3. Idiopathic calcinosis: This type of calcinosis occurs for no apparent reason, and the exact cause is not known. Idiopathic calcinosis can affect people of all ages and can cause calcium deposits to form in a variety of different tissues.
4. Secondary calcinosis: This type of calcidosis occurs as a result of an underlying medical condition or injury. For example, secondary calcinosis can occur in people with kidney disease, hyperparathyroidism (a condition in which the parathyroid glands produce too much parathyroid hormone), or traumatic injuries.

Treatment for calcinosis depends on the underlying cause and the severity of the condition. In some cases, treatment may involve managing the underlying disease or condition that is causing the calcium deposits to form. Other treatments may include medications to reduce inflammation and pain, physical therapy to improve mobility and strength, and surgery to remove the calcium deposits.

The tumor is typically made up of compact, densely packed osteoblastic cells that resemble normal bone tissue. However, unlike normal bone tissue, osteoblastoma has a markedly increased number of blood vessels and can be quite large before it penetrates the surrounding bone.

The exact cause of osteoblastoma is not known, but it is believed to arise from genetic mutations that occur during fetal development. There are several types of osteoblastoma, including:

* Cartilage-forming osteoblastoma: This type of tumor is composed of both osteoblastic and chondrocytic cells and is typically found in the long bones of the arms and legs.
* Fibrous dysplasia: This is a related condition that also arises from abnormalities in the development of bone, but it is not classified as a tumor.

Osteoblastoma is usually diagnosed with imaging tests such as X-rays, CT scans, or MRI scans, and a biopsy may be performed to confirm the diagnosis. Treatment typically involves surgery to remove the tumor, followed by radiation therapy to prevent recurrence. In rare cases, the tumor may be malignant and require more aggressive treatment.

Prognosis for osteoblastoma is generally good if the tumor is diagnosed and treated early, but it can be challenging to distinguish benign from malignant tumors based on imaging studies alone. Therefore, biopsy and careful follow-up are essential to ensure that any recurrences are detected and treated promptly.

The alveolar bone is a specialized type of bone that forms the socket in which the tooth roots are embedded. It provides support and stability to the teeth and helps maintain the proper position of the teeth in their sockets. When the alveolar bone is lost, the teeth may become loose or even fall out completely.

Alveolar bone loss can be detected through various diagnostic methods such as dental X-rays, CT scans, or MRI scans. Treatment options for alveolar bone loss depend on the underlying cause and may include antibiotics, bone grafting, or tooth extraction.

In the context of dentistry, alveolar bone loss is a common complication of periodontal disease, which is a chronic inflammatory condition that affects the supporting structures of the teeth, including the gums and bone. The bacteria that cause periodontal disease can lead to the destruction of the alveolar bone, resulting in tooth loss.

In addition to periodontal disease, other factors that can contribute to alveolar bone loss include:

* Trauma or injury to the teeth or jaw
* Poorly fitting dentures or other prosthetic devices
* Infections or abscesses in the mouth
* Certain systemic diseases such as osteoporosis or cancer

Overall, alveolar bone loss is a significant issue in dentistry and can have a major impact on the health and function of the teeth and jaw. It is essential to seek professional dental care if symptoms of alveolar bone loss are present to prevent further damage and restore oral health.

There are several types of bone cysts, including:

1. Simple bone cysts: These are the most common type of bone cyst and typically occur in children and young adults. They are filled with air or fluid and do not contain any cancerous cells.
2. Angiomatous cysts: These are smaller than simple bone cysts and are usually found near the ends of long bones. They are also filled with blood vessels and do not contain any cancerous cells.
3. Unicameral (simple) bone cysts: These are similar to simple bone cysts but are larger and may be more complex in shape.
4. Multicameral bone cysts: These are larger than unicameral bone cysts and may contain multiple chambers filled with air or fluid.
5. Enchondromas: These are benign tumors that occur within the cartilage of a bone. They are usually found in the long bones of the arms and legs.
6. Chondromyxoid fibromas: These are rare, benign tumors that occur in the cartilage of a bone. They are typically found in the long bones of the arms and legs.
7. Osteochondromas: These are benign tumors that arise from the cartilage and bone of a joint. They are usually found near the ends of long bones.
8. Malignant bone cysts: These are rare and can be cancerous. They may occur in any bone of the body and can be aggressive, spreading quickly to other areas of the body.

The symptoms of bone cysts can vary depending on their size and location. They may cause pain, swelling, and limited mobility in the affected limb. In some cases, they may also lead to fractures or deformities.

Diagnosis of bone cysts usually involves imaging tests such as X-rays, CT scans, or MRI scans. A biopsy may also be performed to confirm the diagnosis and rule out other possible conditions.

Treatment for bone cysts depends on their size, location, and severity. Small, asymptomatic cysts may not require any treatment, while larger cysts may need to be drained or surgically removed. In some cases, medication such as bisphosphonates may be used to help reduce the risk of fractures.

In conclusion, bone cysts are abnormalities that can occur in any bone of the body. They can be benign or malignant and can cause a range of symptoms depending on their size and location. Diagnosis is usually made through imaging tests, and treatment may involve observation, draining, or surgical removal.

Synonyms: cartilage tumor, chondroid tumor, chondromatosis.

Etymology: From the Greek words "chondros," meaning cartilage, and "oma," meaning tumor.

Examples of Chondroma in a sentence:

1. The patient was diagnosed with a chondroma in their knee joint, which was causing pain and stiffness.
2. The surgeon removed the chondroma from the patient's lung, which had been compressing the bronchus and causing difficulty breathing.
3. The chondroma in the patient's heart was monitored with regular imaging studies to ensure it did not grow or cause any further complications.
4. The patient was advised to avoid heavy lifting or bending to prevent exacerbating their chondroma in the spine.

Tibial fractures can range in severity from minor cracks or hairline breaks to more severe breaks that extend into the bone's shaft or even the joint. Treatment for these injuries often involves immobilization of the affected leg with a cast, brace, or walking boot, as well as pain management with medication and physical therapy. In some cases, surgery may be necessary to realign and stabilize the bone fragments.

Note: A malunited fracture is sometimes also referred to as a "nonunion fracture" or "fracture nonunion".

The word "holoprosencephaly" comes from the Greek words "holos," meaning "whole," "prosencephalon," meaning "front part of the brain," and "-ly," indicating a condition or characteristic. The term was first used in the medical literature in the late 19th century to describe this specific type of brain malformation.

In individuals with holoprosencephaly, the two hemispheres of the brain do not properly separate, leading to various abnormalities and impairments. Depending on the severity and location of the defect, symptoms can range from mild to severe and may include:

1. Facial abnormalities, such as a single eye or no nose.
2. Cognitive impairments, including intellectual disability and developmental delays.
3. Motor difficulties, such as weakness or paralysis on one side of the body.
4. Seizures and other neurological problems.
5. Delayed speech and language development.
6. Behavioral challenges, including autism and anxiety.

The exact cause of holoprosencephaly is not fully understood, but it is thought to be related to genetic mutations or environmental factors during early fetal development. Diagnosis is typically made through a combination of prenatal imaging, such as ultrasound or MRI, and postnatal examination, including physical examination and neuroimaging studies.

There is no standard treatment for holoprosencephaly, and management of the condition usually involves a multidisciplinary approach involving neurosurgeons, neurologists, developmental pediatricians, and other specialists. Treatment may include surgery to correct physical abnormalities, medication to control seizures or other neurological symptoms, and various forms of therapy to address cognitive, motor, and behavioral challenges.

The prognosis for holoprosencephaly varies depending on the severity of the condition and the presence of any additional birth defects or medical issues. Some individuals with holoprosencephaly may have a relatively mild form of the condition and can lead active, fulfilling lives with appropriate support and management, while others may experience significant cognitive and physical challenges that require ongoing care and support.

Some common types of eye abnormalities include:

1. Refractive errors: These are errors in the way the eye focuses light, causing blurry vision. Examples include myopia (nearsightedness), hyperopia (farsightedness), astigmatism, and presbyopia (age-related loss of near vision).
2. Amblyopia: This is a condition where the brain favors one eye over the other, causing poor vision in the weaker eye.
3. Cataracts: A cataract is a clouding of the lens in the eye that can cause blurry vision and increase the risk of glaucoma.
4. Glaucoma: This is a group of eye conditions that can damage the optic nerve and lead to vision loss.
5. Macular degeneration: This is a condition where the macula, the part of the retina responsible for central vision, deteriorates, leading to vision loss.
6. Diabetic retinopathy: This is a complication of diabetes that can damage the blood vessels in the retina and lead to vision loss.
7. Retinal detachment: This is a condition where the retina becomes separated from the underlying tissue, leading to vision loss.
8. Corneal abnormalities: These are irregularities in the shape or structure of the cornea, such as keratoconus, that can cause blurry vision.
9. Optic nerve disorders: These are conditions that affect the optic nerve, such as optic neuritis, that can cause vision loss.
10. Traumatic eye injuries: These are injuries to the eye or surrounding tissue that can cause vision loss or other eye abnormalities.

Eye abnormalities can be diagnosed through a comprehensive eye exam, which may include visual acuity tests, refraction tests, and imaging tests such as retinal photography or optical coherence tomography (OCT). Treatment for eye abnormalities depends on the specific condition and may include glasses or contact lenses, medication, surgery, or other therapies.

People with HHT have abnormal blood vessels in their skin, mucous membranes, and organs such as the liver, spleen, and lungs. These abnormal vessels are weak and prone to bleeding, which can lead to nosebleeds, bruising, and other complications.

HHT is usually diagnosed based on a combination of clinical symptoms and genetic testing. Treatment typically involves managing symptoms with medications, lifestyle changes, and in some cases, surgery or other interventions to prevent bleeding episodes.

Some of the main symptoms of HHT include:

* Recurring nosebleeds
* Easy bruising
* Petechiae (tiny red spots on the skin)
* Purpura (larger purple spots on the skin)
* Gingival bleeding (bleeding from the gums)
* Epistaxis (nosebleeds)
* Hematuria (blood in the urine)
* Gastrointestinal bleeding

HHT is a relatively rare disorder, affecting about 1 in 5,000 to 1 in 10,000 people worldwide. It can be inherited in an autosomal dominant pattern, meaning that a single copy of the mutated gene is enough to cause the condition. However, some cases may be caused by spontaneous mutations and not be inherited.

There are several types of HHT, including:

* Type 1: The most common type, characterized by recurring nosebleeds and other bleeding episodes.
* Type 2: Characterized by a milder form of the condition with fewer bleeding episodes.
* Type 3: A rare and severe form of HHT that is often associated with other medical conditions such as liver disease or pulmonary hypertension.

HHT can be diagnosed based on clinical findings and laboratory tests, including:

* Physical examination: To look for signs of bleeding and to assess the size and shape of the nose and ears.
* Imaging studies: Such as CT or MRI scans to evaluate the nasal passages and sinuses.
* Blood tests: To check for abnormalities in blood clotting and platelet function.
* Genetic testing: To identify mutations in the genes associated with HHT.

Treatment for HHT is focused on managing symptoms and preventing complications. It may include:

* Nasal decongestants and antihistamines to reduce bleeding and swelling.
* Corticosteroids to reduce inflammation.
* Antifibrinolytic medications to prevent blood clots from breaking down.
* Surgery to repair or remove affected blood vessels.
* Regular monitoring of blood counts and platelet function.

Early diagnosis and treatment can help improve the quality of life for people with HHT. It is important to seek medical attention if symptoms persist or worsen over time.

The exact cause of osteoarthritis is not known, but it is thought to be due to a combination of factors such as genetics, wear and tear on joints over time, and injuries or trauma to the joint. Osteoarthritis can affect any joint in the body, but it most commonly affects the hands, knees, hips, and spine.

The symptoms of osteoarthritis can vary depending on the severity of the condition and which joint is affected. Common symptoms include:

* Pain or tenderness in the joint
* Stiffness, especially after periods of rest or inactivity
* Limited mobility or loss of flexibility
* Grating or crackling sensations when the joint is moved
* Swelling or redness in the affected joint
* Muscle weakness or wasting

There is no cure for osteoarthritis, but there are several treatment options available to manage the symptoms and slow the progression of the disease. These include:

* Pain relief medications such as acetaminophen or nonsteroidal anti-inflammatory drugs (NSAIDs)
* Physical therapy to improve mobility and strength
* Lifestyle modifications such as weight loss, regular exercise, and avoiding activities that exacerbate the condition
* Bracing or orthotics to support the affected joint
* Corticosteroid injections or hyaluronic acid injections to reduce inflammation and improve joint function
* Joint replacement surgery in severe cases where other treatments have failed.

Early diagnosis and treatment of osteoarthritis can help manage symptoms, slow the progression of the disease, and improve quality of life for individuals with this condition.

There are several types of osteosarcomas, including:

1. High-grade osteosarcoma: This is the most common type of osteosarcoma and tends to grow quickly.
2. Low-grade osteosarcoma: This type of osteosarcoma grows more slowly than high-grade osteosarcoma.
3. Chondrosarcoma: This is a type of osteosarcoma that arises in the cartilage cells of the bone.
4. Ewing's family of tumors: These are rare types of osteosarcoma that can occur in any bone of the body.

The exact cause of osteosarcoma is not known, but certain risk factors may increase the likelihood of developing the disease. These include:

1. Previous radiation exposure
2. Paget's disease of bone
3. Li-Fraumeni syndrome (a genetic disorder that increases the risk of certain types of cancer)
4. Familial retinoblastoma (a rare inherited condition)
5. Exposure to certain chemicals, such as herbicides and industrial chemicals.

Symptoms of osteosarcoma may include:

1. Pain in the affected bone, which may be worse at night or with activity
2. Swelling and redness around the affected area
3. Limited mobility or stiffness in the affected limb
4. A visible lump or mass on the affected bone
5. Fractures or breaks in the affected bone

If osteosarcoma is suspected, a doctor may perform several tests to confirm the diagnosis and determine the extent of the disease. These may include:

1. Imaging studies, such as X-rays, CT scans, or MRI scans
2. Biopsy, in which a sample of tissue is removed from the affected bone and examined under a microscope for cancer cells
3. Blood tests to check for elevated levels of certain enzymes that are produced by osteosarcoma cells
4. Bone scans to look for areas of increased activity or metabolism in the bones.

There are several types of hypertrophy, including:

1. Muscle hypertrophy: The enlargement of muscle fibers due to increased protein synthesis and cell growth, often seen in individuals who engage in resistance training exercises.
2. Cardiac hypertrophy: The enlargement of the heart due to an increase in cardiac workload, often seen in individuals with high blood pressure or other cardiovascular conditions.
3. Adipose tissue hypertrophy: The excessive growth of fat cells, often seen in individuals who are obese or have insulin resistance.
4. Neurological hypertrophy: The enlargement of neural structures such as brain or spinal cord due to an increase in the number of neurons or glial cells, often seen in individuals with neurodegenerative diseases such as Alzheimer's or Parkinson's.
5. Hepatic hypertrophy: The enlargement of the liver due to an increase in the number of liver cells, often seen in individuals with liver disease or cirrhosis.
6. Renal hypertrophy: The enlargement of the kidneys due to an increase in blood flow and filtration, often seen in individuals with kidney disease or hypertension.
7. Ovarian hypertrophy: The enlargement of the ovaries due to an increase in the number of follicles or hormonal imbalances, often seen in individuals with polycystic ovary syndrome (PCOS).

Hypertrophy can be diagnosed through various medical tests such as imaging studies (e.g., CT scans, MRI), biopsies, and blood tests. Treatment options for hypertrophy depend on the underlying cause and may include medications, lifestyle changes, and surgery.

In conclusion, hypertrophy is a growth or enlargement of cells, tissues, or organs in response to an excessive stimulus. It can occur in various parts of the body, including the brain, liver, kidneys, heart, muscles, and ovaries. Understanding the underlying causes and diagnosis of hypertrophy is crucial for effective treatment and management of related health conditions.

The protein encoded by this gene is member of the TGFβ superfamily. Bone morphogenetic proteins are known for their ability to ... Bone morphogenetic proteins were originally identified by an ability of demineralized bone extract to induce endochondral ... "Expression of bone morphogenetic proteins (BMP), BMP receptors, and BMP associated proteins in human trabecular meshwork and ... Bone morphogenetic protein, Developmental genes and proteins, TGFβ domain). ...
Spinal Fusion and Bone Morphogenetic Protein Reddi AH (1997). "Bone morphogenetic proteins: an unconventional approach to ... BMP: The What and the Who BMPedia - the Bone Morphogenetic Protein Wiki Bone+Morphogenetic+Proteins at the US National Library ... Blázquez-Medela, Ana M.; Jumabay, Medet; Boström, Kristina I. (2019-01-04). "Beyond the bone: Bone morphogenetic protein ... "Bone Morphogenetic Protein" in the scientific literature in the Journal of Dental Research in 1971. Bone induction is a ...
... or BMP7 (also known as osteogenic protein-1 or OP-1) is a protein that in humans is encoded by the ... The protein encoded by this gene is a member of the TGF-β superfamily. Like other members of the bone morphogenetic protein ... Reddi AH (July 2000). "Bone morphogenetic proteins and skeletal development: the kidney-bone connection". Pediatric Nephrology ... bone morphogenetic protein 7 (BMP-7) versus autologous bone grafting for tibial fractures]". Der Unfallchirurg (in German). 110 ...
... (BMP10) is a protein that in humans is encoded by the BMP10 gene. BMP10 is a polypeptide ... Bone morphogenetic proteins are known for their ability to induce bone and cartilage development. BMP10 is categorized as a BMP ... Developmental genes and proteins, Bone morphogenetic protein, TGFβ domain, All stub articles, Human chromosome 2 gene stubs). ... "Entrez Gene: bone morphogenetic protein 10". Neuhaus H, Rosen V, Thies RS (February 1999). "Heart specific expression of mouse ...
... or BMP-2 belongs to the TGF-β superfamily of proteins. BMP-2 like other bone morphogenetic ... Bone morphogenetic protein 2 has been shown to interact with BMPR1A. Bone morphogenetic protein 2 is shown to stimulate the ... As an adjuvant to allograft bone or as a replacement for harvested autograft, bone morphogenetic proteins (BMPs) appear to ... Blázquez-Medela AM, Jumabay M, Boström KI (January 2019). "Beyond the bone: Bone morphogenetic protein signaling in adipose ...
... (BMP8A) is a protein that in humans is encoded by the BMP8A gene. BMP8A is a polypeptide member ... It, like other bone morphogenetic proteins (BMPs), is involved in the development of bone and cartilage. BMP8A may be involved ... Bone morphogenetic protein, Developmental genes and proteins, TGFβ domain, All stub articles, Human chromosome 1 gene stubs). ... "Entrez Gene: bone morphogenetic protein 8a". Human BMP8A genome location and BMP8A gene details page in the UCSC Genome Browser ...
"Entrez Gene: BMP4 bone morphogenetic protein 4". Miyazono K, Kamiya Y, Morikawa M (January 2010). "Bone morphogenetic protein ... type II receptor for bone morphogenetic protein-4 that forms differential heteromeric complexes with bone morphogenetic protein ... Bone morphogenetic protein 4 is a protein that in humans is encoded by BMP4 gene. BMP4 is found on chromosome 14q22-q23. BMP4 ... It, like other bone morphogenetic proteins, is involved in bone and cartilage development, specifically tooth and limb ...
... is a protein that in humans is encoded by the BMP6 gene. The protein encoded by this gene is a ... Bone morphogenetic proteins are known for their ability to induce the growth of bone and cartilage. BMP6 is able to induce all ... The bone morphogenetic proteins (BMPs) are a family of secreted signaling molecules that can induce ectopic bone growth. BMPs ... 2001). "Effect of bone morphogenetic protein-6 on haemopoietic stem cells and cytokine production in normal human bone marrow ...
2000). "Bone morphogenetic protein 1 is an extracellular processing enzyme of the laminin 5 gamma 2 chain". J. Biol. Chem. 275 ... Laminin subunit gamma-2 is a protein that in humans is encoded by the LAMC2 gene. Laminins, a family of extracellular matrix ... Each laminin chain is a multidomain protein encoded by a distinct gene. Several isoforms of each chain have been described. ... 2001). "Involvement of activator protein 1 complexes in the epithelium-specific activation of the laminin gamma2-chain gene ...
"Entrez Gene: NOG noggin". Blázquez-Medela AM, Jumabay M, Boström KI (May 2019). "Beyond the bone: Bone morphogenetic protein ... superfamily signaling proteins, such as bone morphogenetic protein 4 (BMP4). By diffusing through extracellular matrices more ... BMPedia - the Bone Morphogenetic Protein Wiki[permanent dead link] Noggin publications, gene expression data, sequences and ... Hall AK, Burke RM, Anand M, Dinsio KJ (July 2002). "Activin and bone morphogenetic proteins are present in perinatal sensory ...
A. Hari Reddi entitled Bone Morphogenetic Proteins, Stem Cells and Regenerative Medicine.). Reddi AH, Reddi A (2009). "Bone ... Babitt JL, Huang FW, Xia Y, Sidis Y, Andrews NC, Lin HY (2007). "Modulation of bone morphogenetic protein signaling in vivo ... Based on this definition, bone morphogenetic proteins (BMPs) are metabologens, since they are involved in iron homeostasis, ... Schulz TJ, Tseng YH (2009). "Emerging Role of Bone Morphogenetic Proteins in Adipogenesis and Energy Metabolism". Cytokine ...
"Bone morphogenetic protein 1 is an extracellular processing enzyme of the laminin 5 gamma 2 chain". J. Biol. Chem. 275 (30): ... "HIV-protein-mediated alterations in T cell interactions with the extracellular matrix proteins and endothelium". Arch. Immunol ... The protein encoded by this gene is the alpha-3 chain of laminin 5, which is a complex glycoprotein composed of three subunits ... Laminin subunit alpha-3 is a protein that in humans is encoded by the LAMA3 gene. Laminins are basement membrane components ...
... , also known as osteogenin, is a protein in humans that is encoded by the BMP3 gene. The protein ... It, like other bone morphogenetic proteins (BMP's) is known for its ability to induce bone and cartilage development. It is a ... "Bone morphogenetic protein-3 is a negative regulator of bone density". Nature Genetics. 27 (1): 84-8. doi:10.1038/83810. PMID ... Bone morphogenetic protein, Developmental genes and proteins, TGFβ domain, All stub articles, Human chromosome 4 gene stubs). ...
Core AB, Canali S, Babitt JL (2014). "Hemojuvelin and bone morphogenetic protein (BMP) signaling in iron homeostasis". ... hereditary hemochromatosis protein, transferrin receptor 2, bone morphogenic protein 6 (BMP6), matriptase-2, neogenin, BMP ... Hepcidin is a protein that in humans is encoded by the HAMP gene. Hepcidin is a key regulator of the entry of iron into the ... NMR studies showed a new model for hepcidin: at ambient temperatures, the protein interconverts between two conformations, ...
"Biodegradable Gelatin Microparticles as Delivery Systems for the Controlled Release of Bone Morphogenetic Protein-2". Acta ... 5 (4): 1126-1138. doi:10.1016/j.actbio.2008.04.002. PMC 3018807. PMID 18474452.{{cite journal}}: CS1 maint: url-status (link) ... 5): 1222-1230. doi:10.1002/jbm.a.35093. PMC 3966975. PMID 24458783. (CS1 maint: url-status, Wikipedia articles that are too ...
... fibroblast growth factor 8 and bone morphogenetic protein), transcription factors (T-box, Pax, Nkx2-5, GATA-6, and Forkhead), ... and gap junction proteins (Connexin). The cardiac neural crest also contributes the smooth muscle of the great arteries.[ ... 16 (5): 635-8. doi:10.1097/01.RVI.0000161372.87971.84. PMID 15872317. Parker SE, Mai CT, Canfield MA, Rickard R, Wang Y, Meyer ... 5 (1): 212-7. doi:10.1053/pcsu.2002.31497. PMID 11994881. Haskal ZJ (2005). "SIR 2005 Annual Meeting Film Panel Case: ...
Other bone morphogenetic proteins are also known to impact corticogenesis in the mouse. Bmp2, 4, 5, and 6 are expressed during ... In mice, bone morphogenetic protein 7 (Bmp-7), is an important regulator in corticogenesis, though it is not understood whether ... a motor protein that affects intercellular movement such as protein sorting and the process of cell division. Another protein ... DAB1 is a regulator protein downstream of the reelin receptors. This protein is located inside cells residing in the ...
"Electrostatics and N-glycan-mediated membrane tethering of SCUBE1 is critical for promoting bone morphogenetic protein ... This protein is expressed in platelets and endothelial cells and may play an important role in vascular biology. GRCh38: ... Chen QH, Lin D, Zhou J, Deng G (2016). "Role of signal peptide-Cub-Egf domain-containing protein-1 in serum as a predictive ... Signal peptide, CUB domain and EGF like domain containing 1 is a protein that in humans is encoded by the SCUBE1 gene. This ...
"Differentiation of human pluripotent teratocarcinoma stem cells induced by bone morphogenetic protein-2". Reproduction, ... Below is a list of genes/protein products that can be used to identify various types of stem cells, or functional assays that ... Perry SS, Wang H, Pierce LJ, Yang AM, Tsai S, Spangrude GJ (April 2004). "L-selectin defines a bone marrow analog to the thymic ... Stahl J, Wobus AM, Ihrig S, Lutsch G, Bielka H (September 1992). "The small heat shock protein hsp25 is accumulated in P19 ...
"Bone Morphogenetic Protein-1: The Type I Procollagen C-Proteinas". Scott, Ian C.; Blitz, Ira L.; Pappano, William N.; Maas, ... In a study in 1996, Greenspan's lab showed that Bone Morphogenetic Protein 1 (BMP-1) is a protease responsible for the ... Kessler, E., Takahara, K., Biniaminov, L., Brusel, M., & Greenspan, D. S. (1996). Bone morphogenetic protein-1: the type I ... Hopkins, Delana R.; Keles, Sunduz; Greenspan, Daniel S. (2007). "The bone morphogenetic protein 1/Tolloid-like ...
However it has been demonstrated that hemojuvelin interacts with bone morphogenetic protein (BMP), possibly as a co-receptor, ... Li J, Ye L, Kynaston HG, Jiang WG (February 2012). "Repulsive guidance molecules, novel bone morphogenetic protein co-receptors ... "Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression". Nat. Genet. 38 (5): 531-9. doi:10.1038/ ... "Pro-protein convertases control the maturation and processing of the iron-regulatory protein, RGMc/hemojuvelin". BMC Biochem. 9 ...
2000). "Bone morphogenetic protein receptor complexes on the surface of live cells: a new oligomerization mode for serine/ ... Vitt U, Mazerbourg S, Klein C, Hsueh A (2002). "Bone morphogenetic protein receptor type II is a receptor for growth ... Vitt UA, Mazerbourg S, Klein C, Hsueh AJ (2003). "Bone morphogenetic protein receptor type II is a receptor for growth ... The cell surface receptor through which GDF9 generates a signal is the bone morphogenetic protein type II receptor (BMPR2). ...
"Conversion of the Nipple to Hair-Bearing Epithelia by Lowering Bone Morphogenetic Protein Pathway Activity at the Dermal- ... "Rescue of the parathyroid hormone-related protein knockout mouse demonstrates that parathyroid hormone-related protein is ... Mammary glands are true protein factories, and several labs have constructed transgenic animals, mainly goats and cows, to ... milk protein production, and regulates osmotic balance and tight junction function. Laminin and collagen in myoepithelial ...
... served as the 3rd largest site in the nation for the trial of bone morphogenetic protein (BMP) - the first use of biologics in ... Disc Disease by Using Stand Alone Anterior Lumbar Interbody Fusion Cages and Recombinant Human Bone Morphogenetic Protein-2: as ... of Anterior Lumbar Interbody Arthrodesis with Use of Interbody Fusion Cages and recombinant Human Bone Morphogenetic Protein-2 ... of Anterior Lumbar Interbody Arthrodesis with Use of Interbody Fusion Cages and Recombinant Human Bone Morphogenetic Protein-2 ...
"Conversion of the nipple to hair-bearing epithelia by lowering bone morphogenetic protein pathway activity at the dermal- ... The tear fluid and urine of male mice also contains pheromones, such as major urinary proteins. Mice detect pheromones mainly ... In the house mouse, the major urinary protein (MUP) gene cluster provides a highly polymorphic scent signal of genetic identity ... "Identification of protein pheromones that promote aggressive behaviour". Nature. 450 (7171): 899-902. Bibcode:2007Natur.450.. ...
"Enhanced expression of type I receptors for bone morphogenetic proteins during bone formation". J. Bone Miner. Res. 10 (11): ... The bone morphogenetic protein receptor, type IA also known as BMPR1A is a protein which in humans is encoded by the BMPR1A ... "Bone morphogenetic protein type IA receptor signaling regulates postnatal osteoblast function and bone remodeling". J. Biol. ... "Cartilage-derived morphogenetic proteins and osteogenic protein-1 differentially regulate osteogenesis". J. Bone Miner. Res. 13 ...
"Proteins associated with type II bone morphogenetic protein receptor (BMPR-II) and identified by two-dimensional gel ... The hnRNP proteins have distinct nucleic acid binding properties. The protein encoded by this gene has three repeats of RRM ... Wada K, Inoue K, Hagiwara M (August 2002). "Identification of methylated proteins by protein arginine N-methyltransferase 1, ... Wada K, Inoue K, Hagiwara M (August 2002). "Identification of methylated proteins by protein arginine N-methyltransferase 1, ...
"Proteins associated with type II bone morphogenetic protein receptor (BMPR-II) and identified by two-dimensional gel ... The glucagon receptor is a 62 kDa protein that is activated by glucagon and is a member of the class B G-protein coupled family ... "Receptor activity modifying protein-directed G protein signaling specificity for the calcitonin gene-related peptide family of ... the Receptor activity-modifying protein, and the G-protein C-terminus has been determined using a computational and ...
"Proteins associated with type II bone morphogenetic protein receptor (BMPR-II) and identified by two-dimensional gel ... U7 snRNA-associated Sm-like protein LSm10 is a protein that in humans is encoded by the LSM10 gene. LSM10 has been shown to ... "A novel zinc finger protein is associated with U7 snRNP and interacts with the stem-loop binding protein in the histone pre- ... "Towards a proteome-scale map of the human protein-protein interaction network". Nature. 437 (7062): 1173-8. Bibcode:2005Natur. ...
"Proteins associated with type II bone morphogenetic protein receptor (BMPR-II) and identified by two-dimensional gel ... "Synergistic activation of the insulin gene by a LIM-homeo domain protein and a basic helix-loop-helix protein: building a ... "Transcriptional synergy between LIM-homeodomain proteins and basic helix-loop-helix proteins: the LIM2 domain determines ... LIM homeobox transcription factor 1, alpha, also known as LMX1A, is a protein which in humans is encoded by the LMX1A gene. ...
Bone morphogenetic protein (BMP) cell signaling plays a key role in diverse aspects of cardiac differentiation and ... The AV node is quite compact (~1 x 3 x 5 mm). The AV node lies at the lower back section of the interatrial septum near the ... The AV node is quite compact (~1 x 3 x 5 mm). It is located at the center of Koch's triangle-a triangle enclosed by the septal ... ISBN 978-0-86542-864-5. Gray, Huon H.; Keith D. Dawkins; Iain A. Simpson; John M. Morgan (2002). Lecture Notes on Cardiology. ...
Meanwhile, the overlying ectoderm secretes bone morphogenetic protein (BMP). This induces the roof plate to begin to secrete ... The vertebral bones or intervertebral disks can shatter, causing the spinal cord to be punctured by a sharp fragment of bone. ... Between the dura mater and the surrounding bone of the vertebrae is a space called the epidural space. The epidural space is ... the spinal cord begins at the occipital bone, passing through the foramen magnum and then enters the spinal canal at the ...
... bone morphogenetic protein - bradykinin - bradykinin receptor - BRCA1 - buffer solution C-terminus - C4 photosynthesis - ... protein - protein biosynthesis - Protein Data Bank - protein design - protein expression - protein folding - protein isoform - ... protein P16 - protein P34cdc2 - protein precursor - protein structure prediction - protein subunit - protein synthesis - ... proto-oncogene protein C-kit - proto-oncogene proteins c-abl - proto-oncogene proteins c-bcl-2 - Proto-oncogene proteins c-fos ...
Developmental research in 2004 found that bone morphogenetic protein 4 (BMP4), and its differential expression during ... 11 February 2015), "Evolution of Darwin's finches and their beaks revealed by genome sequencing", Nature, 518 (7539): 371-5, ... John Maynard Smith (1998). "Chapter 5". Evolutionary genetics (2nd ed.). Oxford. ISBN 978-0198502319. Grant 1999, plate 7. ... 5 April 2007), A classification of the bird species of South America, American Ornithologists' Union, archived from the ...
... dorsalizes the developing embryo by binding ventralizing TGFβ proteins such as bone morphogenetic proteins (BMP) ... "Not.S - Xnot protein - Xenopus laevis (African clawed frog) - not.S gene & protein". Larraín J, Bachiller D, Lu B, Agius E, ... There are five named isoforms of this protein that are produced by alternative splicing. CHRD is 23 exons long and has a length ... Chordin (from Greek χορδή, string, catgut) is a protein with a prominent role in dorsal-ventral patterning during early ...
2004). "Proteins associated with type II bone morphogenetic protein receptor (BMPR-II) and identified by two-dimensional gel ... Lymphocyte-specific protein 1 is a protein that in humans is encoded by the LSP1 gene. This gene encodes an intracellular F- ... Huang CK, Zhan L, Ai Y, Jongstra J (1997). "LSP1 is the major substrate for mitogen-activated protein kinase-activated protein ... Harrison RE, Sikorski BA, Jongstra J (2005). "Leukocyte-specific protein 1 targets the ERK/MAP kinase scaffold protein KSR and ...
Alliston T, Ko TC, Cao Y, Liang YY, Feng XH, Chang C, Derynck R (Jun 2005). "Repression of bone morphogenetic protein and ... Alliston T, Ko TC, Cao Y, Liang YY, Feng XH, Chang C, Derynck R (Jun 2005). "Repression of bone morphogenetic protein and ... MDS1 and EVI1 complex locus protein EVI1 (MECOM) also known as ecotropic virus integration site 1 protein homolog (EVI-1) or ... along with other TGF-β family ligands such as bone morphogenic protein (BMP) and activin are involved in regulating important ...
Msx2 induces Sp7 directly, whereas bone morphogenetic protein 2 (BMP2) induces it indirectly through either Dlx5 or Runx2. Once ... Accelerated bone fracture healing was found when researchers implanted Sp7 overexpressing bone marrow stroma cells at a site of ... It was found that the mechanism by which Sp7 expression accelerated bone healing was through triggering new bone formation by ... Along similar mechanistic lines as bone repair is the integration of dental implants into alveolar bone, since the insertion of ...
Therefore, LGR5 might be a receptor for a member of the large family of bone morphogenetic protein antagonists. Moreover, R- ... is a protein that in humans is encoded by the LGR5 gene. It is a member of GPCR class A receptor proteins. R-spondin proteins ... which in turn are homologous to mammalian bone morphogenetic factors (BMPs) such as gremlin and cerberus. ... also known as G-protein coupled receptor 49 (GPR49) or G-protein coupled receptor 67 (GPR67) ...
"Identification and functional characterization of distinct critically important bone morphogenetic protein-specific response ... DNA-binding protein inhibitor ID-1 is a protein that in humans is encoded by the ID1 gene. The protein encoded by this gene is ... E proteins heterodimerize with tissue restricted bHLH proteins such as Myod, NeuroD, etc. to form active transcription ... October 2001). "Protein-protein interaction panel using mouse full-length cDNAs". Genome Research. 11 (10): 1758-65. doi: ...
Meanwhile, the overlying ectoderm secretes bone morphogenetic protein (BMP). This induces the roof plate to begin to secrete ... The neural crest cells that are found outside of a given neuromere will express the same proteins as the cells that are found ... Between the dura mater and the surrounding bone of the vertebrae is a space called the epidural space. The epidural space is ... The Hox genes contain the 183-bp homeobox, which encodes a particular portion of the Hox proteins called the homeodomain. The ...
... gradient of pituitary morphogenesis is dependent on neuroectodermal signals from the infundibular bone morphogenetic protein 4 ... Other essential proteins necessary for pituitary cell proliferation are Fibroblast growth factor 8 (FGF8), Wnt4, and Wnt5. ... An assortment of genes and proteins - such as WNT4, RSPO1, FOXL2, and various estrogen receptors - have been shown to prevent ... May 1, 2002). "Parathyroid hormone is essential for normal fetal bone formation". J Clin Invest. 109 (9): 1173-1182. doi: ...
January 2006). "Bone morphogenetic protein-4 inhibits corticotroph tumor cells: involvement in the retinoic acid inhibitory ... February 2003). "Involvement of bone morphogenetic protein 4 (BMP-4) in pituitary prolactinoma pathogenesis through a Smad/ ... October 2007). "RSUME, a small RWD-containing protein, enhances SUMO conjugation and stabilizes HIF-1alpha during hypoxia". ... 8 (5): 677-8. doi:10.4161/cc.8.5.8065. PMC 2710531. PMID 19223763. Antunica-Noguerol, M; Budziñski, M L; Druker, J; Gassen, N C ...
"The RING domain of PIASy is involved in the suppression of bone morphogenetic protein-signaling pathway". Biochem. Biophys. Res ... E3 SUMO-protein ligase PIAS4 is one of several protein inhibitor of activated STAT (PIAS) proteins. It is also known as protein ... "Entrez Gene: PIAS4 Protein inhibitor of activated STAT, 4". Imoto, Seiyu; Sugiyama Kenji; Muromoto Ryuta; Sato Noriko; Yamamoto ... 2002). "Protein inhibitors of activated STAT resemble scaffold attachment factors and function as interacting nuclear receptor ...
2004). "Proteins associated with type II bone morphogenetic protein receptor (BMPR-II) and identified by two-dimensional gel ... PDZ domain-containing RING finger protein 3 is a protein that in humans is encoded by the PDZRN3 gene. GRCh38: Ensembl release ... The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro". DNA Res. 6 (3): 197-205. doi: ... 4 (5): 1346-58. doi:10.1002/pmic.200300770. PMID 15188402. S2CID 6773754. Santin AD, Zhan F, Bellone S, et al. (2004). "Gene ...
"Bone Morphogenetic Protein-2 Inhibits Differentiation and Mineralization of Cementoblasts in vitro". Journal of Dental Research ... Unlike those in bone, however, these canals in cementum do not contain nerves, nor do they radiate outward. Instead, the canals ... Thus cementoblasts resemble bone-forming osteoblasts but differ functionally and histologically. The cells of cementum are the ... Each cementocyte lies in its lacuna (plural, lacunae), similar to the pattern noted in bone. These lacunae also have canaliculi ...
2004). "Proteins associated with type II bone morphogenetic protein receptor (BMPR-II) and identified by two-dimensional gel ... Tubulin beta-4A chain is a protein that in humans is encoded by the TUBB4A gene. Two tubulin beta-4 chain proteins are encoded ... 2005). "The glutamine-rich region of the HIV-1 Tat protein is involved in T-cell apoptosis". Journal of Biological Chemistry. ... 2003). "Nuclear coactivator-62 kDa/Ski-interacting protein is a nuclear matrix-associated coactivator that may couple vitamin D ...
... induces human osteoblast differentiation through bone morphogenetic protein-2/extracellular signal-regulated kinase 1/2 pathway ... This is due to the tendency of tannins to react with proteins, such as the ones found in saliva. In food and wine pairing, ... proteins and lipids from oxidative damage pursuant to Article 13(1) of Regulation (EC) No 1924/20061". EFSA Journal. 8 (2): ... foods that are high in proteins (such as red meat) are often paired with tannic wines to minimize the astringency of tannins. ...
Bone morphogenetic proteins (BMPs) are transforming growth factor β (TGFβ) superfamily members. BMP2 can either stimulates the ... July 1998). "Differential roles for bone morphogenetic protein (BMP) receptor type IB and IA in differentiation and ... At the early stage of differentiation, the transient increase of C/EBPβ and C/EBPδ mRNA and protein levels are thought to ... cAMP-responsive element binding protein promotes differentiation, while the activation of PPARγ and C/EBPα is also responsive ...
This model only specifies a "bare bones" pattern. Other factors like sonic hedgehog (Shh) and Hox proteins, primary ... Limb formation begins in the morphogenetic limb field, as mesenchymal cells from the lateral plate mesoderm proliferate to the ... In the development of most vertebrate limbs (though not in some amphibians), the cartilage skeleton is replaced by bone later ... Zhu J, Zhang YT, Alber MS, Newman SA (2010). "Bare bones pattern formation: a core regulatory network in varying geometries ...
"HIV-1 Tat interaction with cyclin T1 represses mannose receptor and the bone morphogenetic protein receptor-2 transcription". ... "Entrez Gene: HTATIP2 HIV-1 Tat interactive protein 2, 30kDa". Maruyama K, Sugano S (1994). "Oligo-capping: a simple method to ... King FW, Shtivelman E (2004). "Inhibition of nuclear import by the proapoptotic protein CC3". Mol. Cell. Biol. 24 (16): 7091- ... a protein associated with metastasis suppression". Cell. Mol. Life Sci. 57 (5): 851-8. doi:10.1007/s000180050047. PMID 10892349 ...
2004). "Proteins associated with type II bone morphogenetic protein receptor (BMPR-II) and identified by two-dimensional gel ... 2003). "The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and ... 32 (5): 505-11. doi:10.1124/dmd.32.5.505. PMID 15100172. "Entrez Gene: CES3 carboxylesterase 3 (brain)". Lee CV, Hymowitz SG, ... 4 (5): 1346-58. doi:10.1002/pmic.200300770. PMID 15188402. S2CID 6773754. Ota T, Suzuki Y, Nishikawa T, et al. (2004). " ...
Up-regulation of the bone morphogenetic protein (BMP) signaling pathway is also crucial in developmental and evolutionary ... Swartz, S. M., Bennett, M. B., & Carrier, D. R. (1992). Wing bone stresses in free flying bats and the evolution of skeletal ... The expansion of the long bones in bat wings is at at least partly attributed to paired-box (Pax) homeodomain transcription ... Bats also had to evolve a thinner cortical bone to reduce torsional stresses produced by propulsive downstroke movements. Bats ...
... and bone morphogenetic protein (50% versus 31%). California had higher adjusted risk for reoperation (relative risk [RR] 2.28; ... versus 5%), fusion of three or more levels (10% versus 5%), ...
The HJV gene provides instructions for making a protein called hemojuvelin. Learn about this gene and related health conditions ... Hemojuvelin and bone morphogenetic protein (BMP) signaling in iron homeostasis. Front Pharmacol. 2014 May 13;5:104. doi: ... Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression. Nat Genet. 2006 May;38(5):531-9. doi: ... The HJV gene provides instructions for making a protein called hemojuvelin. This protein is made in the liver, heart, and ...
... with osteocytes of the femoral head dying along with the bone marrow; resorption of the dead tissue by new but weaker osseous ... Bone morphogenetic proteins in total hip arthroplasty, osteonecrosis and trauma surgery. Expert Rev Med Devices. 2008 Mar. 5(2 ... As bone death occurs, a repair process takes place as dead bone is removed and replaced by new bone. During this phase, the ... Idiopathic bone necrosis of the femoral head. Early diagnosis and treatment. J Bone Joint Surg [Br]. 1985 Jan. 67(1):3-9. [QxMD ...
Bone morphogenetic protein 1 processes prolactin to a 17-kDa antiangiogenic factor. Proc Natl Acad Sci U S A 2007; 104:10010-5 ... Dudley AC, Udagawa T, Melero-Martin JM, Shih SC, Curatolo A, Moses MA, Klagsbrun M. Bone marrow is a reservoir for pro- ... Platelet-derived extracellular vesicles infiltrate and modify the bone marrow during inflammation. Blood Adv 2020; 4:3011-3023 ... Sci Adv 2019; 5:eaav5010. PubMed * Morad G, Moses MA. Brainwashed by extracellular vesicles: the role of extracellular vesicles ...
Bone Morphogenetic Protein 5 - Preferred Concept UI. M0274551. Scope note. A bone morphogenetic protein that may play a role in ... A bone morphogenetic protein that may play a role in CARTILAGE formation. It is a potent regulator of the growth of ... 2009; BONE MORPHOGENETIC PROTEIN 5 was indexed under BONE MORPHOGENETIC PROTEINS 1997-2008. ... where genetic mutations that cause loss of bone morphogenetic protein 5 function result in the formation of small malformed ...
Autologous transplantation with bone marrow-mesenchymal stem cells (BMSCs)... ... Bone morphogenetic protein-12 induces tenogenic differentiation of mesenchymal stem cells derived from equine amniotic fluid. ... were euthanatized and bone marrow was flushed from the femur and tibia bones with PBS. A mixture of single-cells was obtained ... Wang Q, Sun G, Gao C, Feng L, Zhang Y, Hao J, Zuo E, Zhang C, Li S, Piao F. Bone marrow mesenchymal stem cells attenuate 2,5- ...
... polymorphism of the bone morphogenetic protein 2 (BMP2) in a very large, community-based sample. The study takes advantage of ... Inherited factors are important determinants of peak bone mass, although the influence of genetic factors on bone turnover and ... Over the past 20 years, several candidate genes have been associated bone mineral density (BMD); however, most studies have ... receptor related protein 5 (LRP5) and the 116 T/G (Ser37Ala) ... changes in bone mass with aging is less clear. ...
Purification of bovine bone morphogenetic protein by hydroxyapatite chromatography. Proc Natl Acad Sci U S A. 1984;81(2):371-5 ...
BACKGROUND: Bone morphogenetic protein 5 (BMP5) has been identified as one of the important risk factors for microtia; however ... Mitochondrial dysfunction resulting from the down-regulation of bone morphogenetic protein 5 may cause microtia. ... HNF1α positively regulated DNA repair protein RAD51 homolog 4 (RAD51D) at the protein level but not at the mRNA level. ... The protein expression levels of MDC1 and 53BP1 were also measured. Flow cytometry and MTT assays were used to determine cell ...
... bone morphogenetic protein (BMP) and bone gla protein (BGP) levels [12]. However, the specific mechanism of action of fluoride ... Bone lesions of skeletal fluorosis are complicated and varied, due mainly to the destruction of bone formation and bone ... Categories: Bones/Joints, Bone Cells, Skeletal Fluorosis, Mechanisms of Cellular Toxicity, DNA effects, Osteoblasts ... and bone fragility, before the classic bone change of fluorosis (i.e., osteosclerosis in the spine and pelvis) is detectable by ...
Application of Platelet-Rich Fibrin and Bone Morphogenetic Protein for Full-Mouth Implant-Based Oral Rehabilitation in a Case ... Multiple bone metastases were present in the sternum, scapula, and thighs. The treatment effect was progressive disease for ... We present a rare case of PIACC arising in the mandible with multiple bone metastases and review the previous articles. A 70- ... After visualizing the bleeding point clearly by suction, and the screw was inserted into the bone channel. The bleeding was ...
Bone morphogenetic proteins (BMP) signaling is a critical regulator of cartilage. Bone morphogenetic proteins (BMP) signaling ... gene which encodes ALK2 a type I bone morphogenetic protein (BMP) receptor [5 6 12 Most FOP individuals possess the same ... This facilitates activation of the neighboring protein kinase website that consequently induces downstream transmission ... mutation in FOP appears to alter molecular relationships with the inhibitory protein FKBP12 and destabilize tertiary protein ...
Evaluation of the association between a single-nucleotide polymorphism of bone morphogenetic proteins 5 gene and risk of knee ...
Global Bone Morphogenetic Proteins Market Outlook:. The Global Bone Morphogenetic Proteins Market Size was estimated at USD ... About Bone Morphogenetic Proteins Market. Bone morphogenetic proteins (BMPs) are a group of growth factors also known as ... New Report on Bone Morphogenetic Proteins Market by Trend and Application 2023- 2028 ByVijay. Mar 14, 2023 ... researchers latest report provides a deep insight into the global "Bone Morphogenetic Proteins Market"covering all its ...
Quantative effect of improving osteoinductive property of a material due to applicationof recombinant morphogenetic bone ... J. Bone Joint Surg. Am. 2001; 83: 1-6.. *Gautschi O.P., Frey S.P., Zellweger R. Bone morphogenetic proteins in clinical ... Arosarena O.A., Collins W.L. Bone regeneration in the rat mandible with bone morphogenetic protein-2: a comparison of two ... In this paper we show that application of bone. morphogenetic protein rhBMP-2 in demineralized cancellous. bone blocks provides ...
... and bone morphogenetic proteins hormone synthesis and metabolism in non-vertebrate chordates (Bmps) in inducing thyroid destiny ... Long-time period in vitro culture and characterisation of avian embryonic stem cells with a number of morphogenetic ... Some elements influencing absorption rates of the digestion products of protein and carbohydrate from the proximal jejunum of ... Harvest Parameter Liberalize Acceptable Restrict % Females in harvest , 35% 35-39% , 39% Median age of harvested , 6 years 5-6 ...
Glucocorticoid-induced osteonecrosis and osteoporosis are caused by various factors including dysfunction of bone marrow MSCs. ... such as bone, cartilage, and fat. Glucocorticoids affect a variety of biological processes such as proliferation, ... Bone morphogenetic protein-2 restores mineralization in glucocorticoid-inhibited MC3T3-E1 osteoblast cultures. J Bone Miner Res ... Critical regulation of bone morphogenetic protein-induced osteoblastic differentiation by Delta1/Jagged1-activated Notch1 ...
Human BMP8B(Bone Morphogenetic Protein 8B) ELISA Kit. *Human BMPR2(Bone Morphogenetic Protein Receptor 2) ELISA Kit ... Human BMP8A(Bone Morphogenetic Protein 8A) ELISA Kit. * ... Human BMP5(Bone Morphogenetic Protein 5) ELISA Kit. * ... Human TYROBP(TYRO Protein Tyrosine Kinase Binding Protein) ELISA Kit. *Human UBE2I(Ubiquitin Conjugating Enzyme E2I) ELISA Kit ... Human PTPRQ(Protein Tyrosine Phosphatase Receptor Type Q) ELISA Kit. *Human PTPRS(Protein Tyrosine Phosphatase Receptor Type S ...
Human BMP8B(Bone Morphogenetic Protein 8B) ELISA Kit. *Human BMPR2(Bone Morphogenetic Protein Receptor 2) ELISA Kit ... Human BMP8A(Bone Morphogenetic Protein 8A) ELISA Kit. * ... Human BMP5(Bone Morphogenetic Protein 5) ELISA Kit. * ... Human TYROBP(TYRO Protein Tyrosine Kinase Binding Protein) ELISA Kit. *Human UBE2I(Ubiquitin Conjugating Enzyme E2I) ELISA Kit ... Human PTPRQ(Protein Tyrosine Phosphatase Receptor Type Q) ELISA Kit. *Human PTPRS(Protein Tyrosine Phosphatase Receptor Type S ...
... including phosphatidylinositol 3-kinase and protein kinase B signaling, which is critically implicated in insulin resistance, ... Effects of phosphatidylinositol-3 kinase/protein kinase b/bone morphogenetic protein-15 pathway on the follicular development ... PKB is a member of the serine/threonine protein kinase family and a direct target protein downstream of PI3K. The ... one is the phosphatidylinositol 3 kinase/protein kinase B (PI3K/PKB) pathway, and the other is the mitogen-activated protein ...
... bone morphogenetic protein receptor type 2) mutation carriers [59]. What matters in practice are the clinical consequences of ... Over the last 5 years, new drugs have been identified or suspected as potential risk factors for PAH. Several cases of ... Update of group 5: PH with unclear and/or multifactorial mechanisms. Since the basis of our classification system was ... 5Adult Congenital Heart Centre and National Centre for Pulmonary Hypertension, Royal Brompton and Harefield NHS Trust, and the ...
... bone morphogenetic protein-6 restores bone in aged ovariectomized rats by increasing bone formation and suppressing bone ... Systemically available bone morphogenetic protein two and seven affect bone metabolism. INTERNATIONAL ORTHOPAEDICS 2014. 38(9 ... TSH Prevents Bone Resorption and with Calcitriol Synergistically Stimulates Bone Formation in Rats with Low Levels of ... Vukicevic S.Sevelamer Restores Bone Volume and Improves Bone Microarchitecture and Strength in Aged Ovariectomized Rats . ...
Find and purchase more than 1400 Recombinant Proteins produced in E.coli, Yeast, Baculovirus, or Mammalian cell for your ... Recombinant Human Bone morphogenetic protein 7(BMP7). CSB-EP002744HUe0. E.coli. Recombinant Human Brain-derived neurotrophic ... How to Express A Protein with Bioactivity? Applications of Recombinant Proteins Protein Acetylation: An Important Post- ... Three Technologies Help You Obtain Full-Length Muti-Transmembrane Proteins Protein FAQs CUSABIOs Five Expression Systems ...
Mouse BMP2(Bone Morphogenetic Protein 2) ELISA Kit. *Mouse BMPR1A(Bone Morphogenetic Protein Receptor 1A) ELISA Kit ... Human IGFBP1(Insulin Like Growth Factor Binding Protein 1) ELISA Kit. *Human IGFBP2(Insulin Like Growth Factor Binding Protein ... Human IGFBP3(Insulin Like Growth Factor Binding Protein 3) ELISA Kit. *Human IGFBP4(Insulin Like Growth Factor Binding Protein ... Human MIP1a(Macrophage Inflammatory Protein 1 Alpha) ELISA Kit. *Human MIP1b(Macrophage Inflammatory Protein 1 Beta) ELISA Kit ...
The effect of a fibrin-fibronectin/β-tricalcium phosphate/recombinant human bone morphogenetic protein-2 system on bone ... The effect of varying the particle size of beta tricalcium phosphate carrier of recombinant human bone morphogenetic protein-4 ... The effect of platelet-enriched fibrin glue on bone regeneration in autogenous bone grafts. Huh, J. Y., Choi, B. H., Zhu, S. J. ... The Agrin/Perlecan-Related Protein Eyes Shut Is Essential for Epithelial Lumen Formation in the Drosophila Retina. Husain, N., ...
Chicken BMP2(Bone Morphogenetic Protein 2) ELISA Kit. *Chicken BMP4(Bone Morphogenetic Protein 4) ELISA Kit ... Human IGFBP5(Insulin Like Growth Factor Binding Protein 5) ELISA Kit. *Human IGFBP7(Insulin Like Growth Factor Binding Protein ... Human IGFBP5(Insulin Like Growth Factor Binding Protein 5) ELISA Kit. *Human IGFBP7(Insulin Like Growth Factor Binding Protein ... Human SFRP5(Secreted Frizzled Related Protein 5) ELISA Kit. To Order Contact us below: [email protected] ...
Persani L, Rossetti R, Di Pasquale E, Cacciatore C, Fabre S. The fundamental role of bone morphogenetic protein 15 in ovarian ... a homolog of vertebrate bone morphogenetic proteins (BMPs). Dpp provides a crucial short-range signal that keeps germ cells ... The trimmed protein alignments are provided in Additional file 2: Data S2. Phylogenetic analysis of TGF-β family members was ... Protein sequences used for phylogenetic analysis were downloaded from the NCBI database. A full list of the species and GenBank ...
Goat, prolificacy, bone morphogenetic protein 15 gene, functional analysis. First Page. 463 ... 5, Article 1. https://doi.org/10.3906/vet-1401-97 Available at: https://journals.tubitak.gov.tr/veterinary/vol38/iss5/1 ...
Synergistic effect of Indian hedgehog and bone morphogenetic protein-2 gene transfer to increase the osteogenic potential of ... we induced the overexpression of the growth factors bone morphogenetic protein 2 (BMP-2) and/or Indian hedgehog (IHH) in human ... are promising but impaired by high levels of hypertrophy after chondrogenic induction with several bone morphogenetic protein ... Introduction To stimulate healing of large bone defects research has concentrated on the application of mesenchymal stem cells ...
Lack of bone morphogenetic protein BMP6 induces massive iron overload. Nature Genetics 2009, 41: 478-481. ... molecules HFE and transferrin receptor-2 on the iron phenotype of mice lacking bone morphogenetic protein 6 or hemojuvelin. ... Iron regulates phosphorylation of Smad1/5/8 and gene expression of Bmp6, Smad7, Id1, and Atoh8 in the mouse liver. Blood 2008, ... Hepcidin upregulation by inflammation is independent of Smad1/5/8 signaling by activin B. Blood 2017, 129:533-536. ...
  • 8. Smad1/5 and Smad4 expression are important for osteoclast differentiation. (nih.gov)
  • 12. Smad 1/5 is involved in bone morphogenetic protein-2-induced odontoblastic differentiation in human dental pulp cells. (nih.gov)
  • 14. Endoglin is involved in BMP-2-induced osteogenic differentiation of periodontal ligament cells through a pathway independent of Smad-1/5/8 phosphorylation. (nih.gov)
  • The transforming growth factor-beta (TGF-β) superfamily includes TGF-β isoforms, activins/inhibins, nodal, anti-Müllerian hormone proteins, growth differentiation factors (GDFs), and bone morphogenetic proteins (BMPs), which play critical roles in embryogenesis and adult tissue homeostasis. (nature.com)
  • These data set up that at least one effect of ALK2 gain-of-function mutations in FOP individuals is definitely enhanced chondrogenic differentiation which helps formation of heterotopic endochondral bone. (bioshockinfinitereleasedate.com)
  • The Alk2R206H gain-of-function mutation enhances both canonical (phospho-Smad1/5/8) and noncanonical (phophop38) BMP signaling reactions in the absence of ligand [17 18 23 Furthermore lesion biopsies from FOP individuals and a R206H knockin mouse model exposed that cartilage differentiation happens within regions of fibroproliferation [2 10 11 26 The induction of chondrogenesis is definitely therefore an important early step in the pathology of FOP. (bioshockinfinitereleasedate.com)
  • Normal physiological levels of GCs are essential for development, metabolism, normal osteoblast differentiation, and bone formation. (biomedcentral.com)
  • Enhanced secretion of proteins specific for differentiation toward bone as well as calcium deposition and alkaline phosphatase activity were observed in irradiated cells cultured in a medium not supplemented with osteogenic factors. (class4lasers.com)
  • 15. Activation of the bone morphogenetic protein signaling pathway induces inhibin beta(B)-subunit mRNA and secreted inhibin B levels in cultured human granulosa-luteal cells. (nih.gov)
  • This facilitates activation of the neighboring protein kinase website that consequently induces downstream transmission transduction by phosphorylating BMP-specific Smads (Smad1 Smad5 and Smad8) and/or components of the mitogen-activated protein kinase (MAPK) pathway to regulate gene transcription [14]. (bioshockinfinitereleasedate.com)
  • Bone morphogenic protein is an isolated protein that induces specific cells in our body to form new cartilage and bone. (maxsurg.com)
  • 3. Transforming growth factor β inhibits bone morphogenetic protein-induced transcription through novel phosphorylated Smad1/5-Smad3 complexes. (nih.gov)
  • 9. Transforming growth factor-β1 suppresses bone morphogenetic protein-2-induced mesenchymal-epithelial transition in HSC-4 human oral squamous cell carcinoma cells via Smad1/5/9 pathway suppression. (nih.gov)
  • Of note, treatment with GIP, but not treatment with GLP-1, augmented Smad1/5/8 phosphorylation and transcription of the BMP target gene Id-1 induced by BMP-6 stimulation, suggesting that GIP upregulates BMP receptor signaling that can inhibit FSH-induced progesterone synthesis in rat granulosa cells. (elsevierpure.com)
  • Recent advances in extracellular signaling suggest that extracellular protein phosphorylation is a regulatory mechanism outside the cell. (biomedcentral.com)
  • The list of reported active extracellular protein kinases and phosphatases is growing, and phosphorylation of an increasing number of extracellular matrix molecules and extracellular domains of trans-membrane proteins is being documented. (biomedcentral.com)
  • Here, we use public proteomic databases, collagens - the major components of the extracellular matrix, extracellular signaling molecules and proteolytic enzymes as examples to assess what the roles of extracellular protein phosphorylation may be in health and disease. (biomedcentral.com)
  • We propose that novel tools be developed to help assess the role of extracellular protein phosphorylation and translate the findings for biomedical applications. (biomedcentral.com)
  • Technical advances have significantly contributed to insights into the functional role of extracellular protein phosphorylation. (biomedcentral.com)
  • In principle, phosphorylation of secretory proteins could happen prior to secretion or in the extracellular matrix (ECM). (biomedcentral.com)
  • Alterations in phosphorylation of secreted proteins during their transit through the secretory pathway might interfere with their folding, transport, secretion, release from the cell surface or interaction with other ECM components. (biomedcentral.com)
  • Phosphorylation and dephosphorylation events in the ECM may regulate the processing, assembly, degradation and binding properties of matrix proteins. (biomedcentral.com)
  • In any case, the widespread phosphorylation of extracellular matrix proteins suggests that the mechanism of reversible protein phosphorylation may not only be a mechanism inside cells as widely demonstrated, but may also be a regulatory mechanism outside cells. (biomedcentral.com)
  • One protein in the SIBLING group, osteopontin (OPN), inhibits HA formation, and this inhibition depends on the degree of phosphorylation [ 25 ]. (biomedcentral.com)
  • 13. Inhibition of mTORC1 kinase activates Smads 1 and 5 but not Smad8 in human prostate cancer cells, mediating cytostatic response to rapamycin. (nih.gov)
  • How important such kinase activity maybe for the functions of extracellular proteins is well illustrated by evidence that mutations in secreted kinases can lead to severe disorders. (biomedcentral.com)
  • Our previous studies have demonstrated that insulin signaling pathway has an important role in the pathophysiology of polycystic ovary syndrome (PCOS), including phosphatidylinositol 3-kinase and protein kinase B signaling, which is critically implicated in insulin resistance, androgen secretion, obesity, and follicular development. (intechopen.com)
  • The HJV gene provides instructions for making a protein called hemojuvelin. (medlineplus.gov)
  • Most HJV gene mutations change one of the protein building blocks (amino acids) used to make hemojuvelin. (medlineplus.gov)
  • Mutations in the HJV gene lead to an altered hemojuvelin protein that cannot function properly. (medlineplus.gov)
  • gene which encodes ALK2 a type I bone morphogenetic protein (BMP) receptor [5 6 12 Most FOP individuals possess the same specific R206H substitution in ALK2. (bioshockinfinitereleasedate.com)
  • Meanwhile, 5-AZA-dC suppressed the increase in MGMT and MLH1 gene methylation in osteoblasts treated with low doses of NaF, leading to enhanced expression of MGMT and MLH1 mRNA. (fluoridealert.org)
  • The abnormal methylation of the mismatch repair gene MLH1 can lead to the transcriptional inactivation of mRNA and the loss of protein expression , which will result in defects in the mismatch repair function of the body, thus causing instability of the whole genome and eventually leading to the occurrence of tumours [ 9 ]. (fluoridealert.org)
  • Evaluation of the association between a single-nucleotide polymorphism of bone morphogenetic proteins 5 gene and risk of knee osteoarthritis. (cdc.gov)
  • The kisspeptin, which is the product of the gene and KISS1 stimulates gonadotropin-releasing hormone (GnRH), which binds to a receptor coupled to G (GPR54) protein, which stimulates the release of GnRH by hypothalamic neurons, leading to the secretion of pituitary gonadotropins LH and FSH and sex steroids which in turn will act on the gonads to produce gametes. (fapesp.br)
  • Germline mutations of the gene encoding bone morphogenetic protein receptor ( BMPR ) type 2 are certainly clear examples of established risk factors for PAH development 4 . (ersjournals.com)
  • Bone morphogenetic proteins (BMPs) are a group of growth factors also known as cytokines and as metabologens.Originally discovered by their ability to induce the formation of bone and cartilage, BMPs are now considered to constitute a group of pivotal morphogenetic signals, orchestrating tissue architecture throughout the body. (fremontobserver.com)
  • 16. Small molecule inhibitor of the bone morphogenetic protein pathway DMH1 reduces ovarian cancer cell growth. (nih.gov)
  • At what stages in their secretory pathway such proteins may serve as substrates for kinases is not clear. (biomedcentral.com)
  • 2. Bone morphogenetic protein 2 regulates cell-cell communication by down-regulating connexin43 expression in luteinized human granulosa cells. (nih.gov)
  • Autologous transplantation with bone marrow-mesenchymal stem cells (BMSCs) could be a promising therapeutical approach but its effect on toxic chemical-induced neuropathy remains undetermined. (researchsquare.com)
  • After the development of characteristic phenotypes, rats were given a single bolus tail-vein injection of BMSCs (5×10 7 cells/kg) and followed-up for 5 weeks. (researchsquare.com)
  • What are the most promising anabolic targets (cells, ligands/receptors, intracellular signaling pathways) for diseases and disorders of bone, cartilage, and muscle at this time? (nih.gov)
  • Samples (1 x10(6) cells/ml) from irradiated and non-irradiated cells of each cell line were incubated with or without 5 microg/ml of Fas ligand peptide for 2 h at 37 degrees C in a humidified atmosphere of 5% carbon dioxide (CO2) in air. (nih.gov)
  • As the sponge dissolves, the bone morphogenic protein stimulates the cells to produce new bone. (maxsurg.com)
  • Aggregated mesenchymal cells at the defect, chondrocytes at the hypertrophic cartilage, and osteoblasts adjunct to newly formed woven bone showed intensive proliferating cell nuclear antigen expression. (tmu.edu.tw)
  • Mesenchymal stem cells (MSCs) are multipotent cells capable of differentiating into several tissues, such as bone, cartilage, and fat. (biomedcentral.com)
  • Taken together these findings indicate that laser treatment enhances the in vitro proliferation of Saos-2 cells, and also influences their osteogenic maturation, which suggest it is a helpful application for bone tissue regeneration. (class4lasers.com)
  • 5-HT levels are known to be elevated in PAH 12 and 5-HT acts as growth factor for pulmonary artery smooth muscle cells 13 , 14 , thus possibly contributing to the pathophysiology of PAH development and progression. (ersjournals.com)
  • Fas antigen, also termed APO-1 or CD95, is a transmembrane protein and a member of the tumor necrosis factor receptor/nerve growth factor receptor superfamily which mediates apoptosis upon oligomerization. (nih.gov)
  • Nine (22.5%) out of 40 patients evaluated resulted positive for the presence of germline bone morphogenetic protein receptor ( BMPR) type 2 mutations. (ersjournals.com)
  • Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression. (medlineplus.gov)
  • Furthermore, the DNA methyltransferase inhibitor 5-AZA-dC suppressed cell viability , cell number in S-phase, ALP activity and osteogenesis-related protein levels in osteoblasts treated with low doses of NaF. (fluoridealert.org)
  • In osteoblasts treated with NaF, excessive methylation of p16 has been reported to be induced, causing increased cell proliferation , prolonged S-phase of the cell cycle, and skeletal fluorosis progression, while the methylation inhibitor 5-aza-2-deoxycytidine (5-AZA-dC) reverses the hypermethylation of p16 induced by NaF [ 6 ]. (fluoridealert.org)
  • Evidence for its role in cartilage formation can be seen in MICE , where genetic mutations that cause loss of bone morphogenetic protein 5 function result in the formation of small malformed ears. (nih.gov)
  • Other mutations create a premature stop signal in the instructions for making the hemojuvelin protein resulting in an abnormally small protein. (medlineplus.gov)
  • Mutations in KRIT1, a protein initially identified based on a yeast two-hybrid interaction with the RAS-family GTPase RAP1A, are responsible for the development of the inherited vascular disorder cerebral cavernous malformations (CCM1). (nih.gov)
  • It is a potent regulator of the growth of CHONDROCYTES and the synthesis of cartilage matrix proteins. (nih.gov)
  • Purification of bovine bone morphogenetic protein by hydroxyapatite chromatography. (bvsalud.org)
  • Arosarena O.A., Collins W.L. Bone regeneration in the rat mandible with bone morphogenetic protein-2: a comparison of two carriers. (genescells.ru)
  • ESW treatment significantly promoted BMP-2, BMP-3, BMP-4, and BMP-7 mRNA expression of callus as determined by RT-PCR, and BMP immunoreactivity appeared throughout the bone regeneration period. (tmu.edu.tw)
  • Our findings suggest that BMP play an important role in signaling ESW-activated cell proliferation and bone regeneration of segmental defect. (tmu.edu.tw)
  • Several studies have shown that low-level laser irradiation (LLLI) has beneficial effects on bone regeneration. (class4lasers.com)
  • We present a rare case of PIACC arising in the mandible with multiple bone metastases and review the previous articles. (hindawi.com)
  • Clinical examination revealed an egg-like tumefaction of the alveolar bone in the left premolar region of the mandible. (hindawi.com)
  • Death of bone marrow occurs within 6-12 hours after vascular insult. (medscape.com)
  • Platelet-derived extracellular vesicles infiltrate and modify the bone marrow during inflammation. (harvard.edu)
  • Glucocorticoid-induced osteonecrosis and osteoporosis are caused by various factors including dysfunction of bone marrow MSCs. (biomedcentral.com)
  • The GR is an intracellular protein that is ubiquitously expressed in almost every cell of the organism and interacts with chromatin to modulate the activity of numerous transcription factors in a cell type-specific manner. (biomedcentral.com)
  • Bone morphogenetic proteins (BMP) have been implicated as playing an important role in bone development and fracture healing. (tmu.edu.tw)
  • Therapeutic Outcomes of Low-Level Laser Therapy for Closed Bone Fracture in the Human Wrist and Hand. (class4lasers.com)
  • [ 5 ] Studies have also shown elevated cryofibrinogen levels in atraumatic osteonecrosis. (medscape.com)
  • In this paper we show that application of bone morphogenetic protein rhBMP-2 in demineralized cancellous bone blocks provides great improving osteoinductivity of the material in the ectopic model subcutaneous implantation in rats. (genescells.ru)
  • The model of ectopic subcutaneous implantation to rats is very convenience test system to detect increase in osteoinductivity of materials caused by application of rhBMP-2, and to identify features of ectopic bone formation in these materials. (genescells.ru)
  • Low-level laser therapy enhances the expression of osteogenic factors during bone repair in rats. (class4lasers.com)
  • The aim of this study was to evaluate the effects of low-level laser therapy (LLLT) on bone formation, immunoexpression of osteogenic factors, and biomechanical properties in a tibial bone defect model in rats. (class4lasers.com)
  • Sixty male Wistar rats were distributed into bone defect control group (CG) and laser irradiated group (LG). (class4lasers.com)
  • At present, novel osteoinductive materials containing recombinant bone morphogenetic proteins (rhBMPs) are actively being developed for «regenerative medicine», traumatology and orthopedics. (genescells.ru)
  • A treatment for FOP and anemia of inflammation, as well as BMP driven diseases (certain cancers, cardio-vascular disease, inflammation, hematological disease and bone disorders). (nih.gov)
  • Sickle cell anemia results in bone death secondary to the sickling process and subsequent vascular occlusion. (medscape.com)
  • Research and Clinical Studies that Support Bone Healing and Osteogenesis with Laser Therapy Treatments. (class4lasers.com)
  • Alkaline phosphatase (ALP) was calculated to evaluate bone formation and turnover. (fluoridealert.org)
  • Bone lesions of skeletal fluorosis are complicated and varied, due mainly to the destruction of bone formation and bone resorption balance and the acceleration of bone turnover [ 1 ]. (fluoridealert.org)
  • mRNA and protein expression levels were assessed using qRT-PCR and Western blot assays. (fluoridealert.org)
  • Daily intake of a small dose of fluoride can promote the normal growth and development of teeth and bones, as well as the normal activity of the enzyme system [ 4 ]. (fluoridealert.org)
  • The malignant brain tumors contain CSCs are also thought to show higher NOTCH activity [5]. (scirp.org)
  • abstract = " Extracorporeal shock wave (ESW) is a noninvasive acoustic wave, which has recently been demonstrated to promote bone repair. (tmu.edu.tw)
  • Abstract Objective: The therapeutic outcomes of low-level laser therapy (LLLT) on closed bone fractures (CBFs) in the wrist and hand were investigated in this controlled study. (class4lasers.com)
  • The participants agreed that strategies for activating anabolic pathways in bone, cartilage, and muscle hold considerable potential to yield new therapeutic approaches for diseases relating to individual tissues and for the musculoskeletal system as a whole. (nih.gov)
  • If fluoride is taken in large amounts over a long period of time, fluoride can cause abnormal proliferation and activation of osteoblasts and osteoclasts , leading to skeletal fluorosis, which can lead to pain and damage to joints and bones and even permanent disability [ 3 , 5 ]. (fluoridealert.org)
  • In a previous study of this subject, the osteoblasts of primary cultured mice were found to always proliferate when the fluoride dose was 5-20 mg/L, and the proliferation of osteoblasts was the highest when the fluoride dose was 10 mg/L (preliminary research on this subject). (fluoridealert.org)
  • 17. Smad5 determines murine amnion fate through the control of bone morphogenetic protein expression and signalling levels. (nih.gov)
  • Hemojuvelin plays a role maintaining proper iron levels in the body by controlling the levels of another protein called hepcidin. (medlineplus.gov)
  • A bone morphogenetic protein that may play a role in CARTILAGE formation. (nih.gov)
  • This establishes ALK2 like a plausible restorative target during early chondrogenic phases of lesion formation for avoiding heterotopic bone formation in FOP and additional conditions. (bioshockinfinitereleasedate.com)
  • Also, a higher amount of newly formed bone was observed at 15 days postsurgery. (class4lasers.com)
  • Diisocyanates are the most common cause of occupational asthma from low-molecular weight chemicals, still causing disease in 5-15 % of chronically exposed workers despite improved industrial hygiene efforts. (cdc.gov)
  • They reviewed what is known about anabolic processes of bone, cartilage, and muscle, and progress toward developing anabolic therapies for related disorders. (nih.gov)
  • Hemojuvelin and bone morphogenetic protein (BMP) signaling in iron homeostasis. (medlineplus.gov)
  • Description: A competitive ELISA for quantitative measurement of Human Bone morphogenetic protein 8A(BMP8A) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. (isogem.org)
  • McKay W.F., Peckham S.M., Badura J.M. A comprehensive clinical review of recombinant human bone morphogenetic protein-2 (INFUSE Bone Graft). (genescells.ru)
  • From parallel screens of human fetal brain and HeLa cDNA libraries, we obtained multiple independent isolates of human integrin cytoplasmic domain-associated protein-1 (ICAP-1) as interacting clones. (nih.gov)
  • however, little research has been conducted to determine the effect of LLLT on the treatment of human bone fractures. (class4lasers.com)
  • A fragment containing the N-terminal 272 amino acid residues of KRIT1, a region lacking similarity to any known protein upon database searches, was used as bait. (nih.gov)
  • The participants noted that, while the bone, cartilage, and muscle fields are at different stages of research and therapeutic development, all would benefit from additional studies. (nih.gov)
  • As the function of the KRIT1 protein and its role in CCM pathogenesis remain unknown, we performed yeast two-hybrid screens to identify additional protein binding partners. (nih.gov)
  • Description: A sandwich ELISA kit for detection of Bone Morphogenetic Protein 8A from Rat in samples from blood, serum, plasma, cell culture fluid and other biological fluids. (isogem.org)